>6523:1:C41 [S20X]
EWDREINNYTSLIHSLIEEXQNQQEKNEQELLELDKWASLW
>6173:1:
EAIIRILQQLEFIHKRIGRRRRRRRR
>15759:1:P-75
EMTWEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEK
>15309:1:SARS-CoV-S (1134-1189)
LDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE
>6036:1:
KGEAMHGQVDCSPGI
>15470:1:SC27EK
WEEWDKKIEEYTKKIEELIKKSEEQQK
>5925:1:Vif (41-55)
RHHYESPHPRISSEV
>4637:1:NS5A-derived peptide C5A [I10L,V13L]
SWLRDIWDWLCELLSDFK
>15165:1:229E-HCoV-HR1P
AASFNKAMTNIVDAFTGVNDAITQTSQALQTVATALNKIQDVVNQQGNSLNHLTSQ
>15535:1:Alloferon (8-13)
QHGVHG
>2537:1:Leaf cyclotide 1, Vhl-1
SISCGESCAMISFCFTEVIGCSCKNKVCYLN
>16964:1:SARS-CoV-S (1149–1186)
GDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELG
>6124:1:LEDGF (361-370)[D366A][D369A]
WNSLKIANLAV
>6574:1:
SGIDQEQNNLTRLIEAQIHELQLTQWKIKQLLARILK
>6061:1:
MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLEL
>6431:1:
PFVFLE
>6718:1:P28
TEVSEALGGAGLTGGFYEPL
>6348:1:
LEYSI
>142:1:LL-37 (18-37), KR-20
KRIVQRIKDFLRNLVPRTES
>15427:1:T21N36
RIQQIEQKIHHIEQRIQQIEQRISGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
>841:1:Maximin 4
GIGGVLLSAGKAALKGLAKVLAEKYAN
>15562:1:Eval418-FH5
LWHHIWHTVHHLI
>6098:1:
TTWEAWDRAIAEYAARIEALIRALQEQQEKNEAALREL
>6562:1:
RGGLSGIVQQQNNLLRAIEAQQHLLQ
>16972:1:SARS-CoV-2-S (1169-1198)-K, IPB08
ISGINASVVNIQKEIDRLNEVAKNLNESLIK
>12198:1:Cycloviolin C
GIPCGESCVFIPCLTTVAGCSCKNKVCYRN
>15718:1:FIV Egp (746-780)
FYEIIMDIEQNNVQGKKGIQQLQKWEDWVGWIGNI
>15348:1:HCV (1975-1992)[R4D;D5,8,16R;E12K;K18E]
SWLDRIWRWICKVLSRFE
>6427:1:
NKPFVFLM
>13336:1:D5F
FAVGLRAIKRALKKLRRGVRKVAKDL
>15431:1:(T21N36)3 
>15431:2:(T21N36)3 
>15431:3:(T21N36)3 
>154:1:LL-37 (13-32)[I13G,G14I,I20E,V21F]
GIKEFKREFQRIKDFLRNLV
>6165:1:
EAIIRILQELLFKHFRIGRRRRRRRR
>6020:1:
VTNTATIM
>1136:1:Caerin-1.1
GLLSVLGSVAKHVLPHVVPVIAEHL
>15466:1:SC31EK
WEEWDKKIEEYTKKIEELIKKSEEQQKKNEK
>3808:1:Retrocyclin-112, RC-112
GicrcicGrGicrcicGr
>15523:1:Complement C4 (1353-1369), G17K
GLEEELQFSLGSKINVK
>15173:1:EK0-1, HCoV-OC43-HR2P [N17K,R18K,Q20E,V25K,N27E]
SLDYINVTFLDLQDEMKKLEEAIKKLEQSYINLKDI
>15489:1:MTSC25EK
MTWEEWDKKIEEYTKKIEELIKKSEEQ
>5899:1:EBR28 [L3A]
YQALIRMIYKNI
>16548:1:Deca-(ARG)8
wrrrrrrrrG
>15364:1:HCV gp (714-725)
IKWEYVLLLFLL
>15734:1:LP-69
IEELLKKAEEQQKKNEEELKX
>15221:1:MERS-S (1260-1280) [Y5,S9Ala-4-pen]
LDLTXEMLXLQQVVKALNESY
>15671:1:LP-90
IEELLKKAEEQQKKNEEELKKLEX
>15558:1:Eval418
LWGEIWNTVKGLI
>6237:1:IN (97-108)[L6A]
TAYFLAKLAGRW
>6722:1:
LNWGTPDWDVRNCVGVLWCP
>15299:1: 
>15299:2: 
>15333:1:Retro-HCV (1975-1992)
KFDSLVECIWDWIDRLWS
>6519:1:C41 [Q29X]
EWDREINNYTSLIHSLIEESQNQQEKNEXELLELDKWASLW
>15276:1:Caerin 1.1 [E23A,H24A]
GLLSVLGSVAKHVLPHVVPVIAAAL
>7758:1:
HRILMRIRQMMA
>6260:1:IN (129-139)[F11A]
ACWWAGIKQEA
>6630:1:Enfuvirtide [S138I], T-20 [S138I]
YTSLIHSLIEEIQNQQEKNEQELLELDKWASLWNWF
>15325:1:HCV (1977-1992)
LRDIWDWICEVLSDFK 
>15260:1:PEDV-S HR2M, PCov-S HR2M
FNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDL
>355:1:N-[RLLR]3 
APKAMRLLRRLLRRLLR
>15519:1: IgG1 (363-372)[L5A]
NQVSATCSVK
>6626:1:Enfuvirtide [S138G], T-20 [S138G]
YTSLIHSLIEEGQNQQEKNEQELLELDKWASLWNWF
>2370:1:Piscidin 1, Moronecidin
FFHHIFRGIVHVGKTIHRLVTG
>15722:1:LP-56
WEQKIEELLKKAEEQQKKNEEELKKAEEAX
>15372:1:HCV gp (713-724) scrambled
LKLFEVYLILWLA
>15688:1:RSV Fgp (497-515)[I3A;N4,A8,R11,E15 - S-ALA-4-pen]
EKAXQSLXFIXKSDXLLHNV
>6558:1:C16- N23 
RQLLSGIVQQQNNLLRAIEAQQH
>6108:1:LEDGF (361-370)
WNSLKIDNLDV
>15667:1:LP-81
WEQKIEELLKKAEEQQKKNEEELKKLEX
>15237:1:MERS-S (1260-1280) [M7Nle; Q12,A16Ala-4-pen; Y21F]
LDLTYEXLSLQXVVKXLNESF
>6221:1:IN (152-161)
ESMNKELKKI
>6313:1:Cathelicidin-4 [R12P][R13P], Indolicidin [R12P][R13P]
ILPWKWPWWPWPP
>15186:1:
FEEFSKKFEEFSKKFEEFSKKFEEFSKKFEEFSKKXK
>15539:1:Alloferon (1-10)
HGVSGHGQHG
>15169:1:HCoV-NL63-HR1P
AASFNKAINNIVASFSSVNDAITQTAEAIHTVTIALNKIQDVVNQQGSALNHLTSQ
>15493:1:MTSC21EK
MTWEEWDKKIEEYTKKIEELIKK
>5929:1:Vif (66-81)
ITTYWGLHTGERDWHL
>6606:1:P46, GBV-C E2 (136-153)
DTVVELSEWGVPCATCIL
>6256:1:IN (129-139)[K8A]
ACWWAGIAQEF
>15240:1:RG-HCV (1677-1691)-K
RGGSVVIVGRIILSGRK
>7294:1:
RWWRWWR
>15610:1:LP-40
YTSLIHSLIEESQNQQEKNEQELLELDX
>15305:1:SARS-CoV-S (889–926)
NGIGVTQNVLYENQKQIANQFNKAISQIQESLTTTSTA
>15755:1:P-71
IEEYTKKIEEILKKSEEQQKKNEEELKKLEK
>2307:1:Isracidin, Alpha-S1-casein
RPKHPIKHQGLPQEVLNENLLRF
>6344:1:
LLEYSI
>5991:1:HIV-1 RT (166-185)
KILEPFRKQNPDIVIYQYMD
>6128:1:HRP2 (483-493)
WKFALKVDSPDV
>15647:1:SARS-CoV Sgp (890–909)[T894A]
GIGVAQNVLYENQKQIANQF
>16968:1:SARS-CoV-2-S (1175-1205), IPB04
SVVNIQKEIDRLNEVAKNLNESLIDLQELGK
>15217:1:MERS-S (1260-1280)
LDLTYEMLSLQQVVKALNESY
>15702:1:RSV Fgp (488-522)
FDASISQVNEKINQSLAFIRKSDELLHNVNAGKST
>15352:1:SARS-S (920-953)
LTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFG
>18560:1:Nodupetide
AVXGVl
>18999:1:Xylapeptide B
LPXVa
>5987:1:Ncap-MT
APKEWMAWAREIAAYAKLIAALI
>6352:1:
LLE
>158:1:Cathelicidin-6 (1-18)[F6I,F10L, L17I]
GRFKRIRKKLKKLFKKIS
>15597:1:Pa-MAP 1.8, Antifreeze peptide analogue
LAAALTAKATALTAKLTALAAALTAKAT
>2254:1:Hyposin-5, Hyposin-HA4
FRPALIVRTKGTRL
>3916:1:Caerin-1.5
GLLSVLGSVVKHVIPHVVPVIAEHL
>6647:1:
GCKKYRRFRWKFKGKFWFWG
>6217:1:IN (106-112)
GRWPVKT
>15201:1:SARS-CoV (1028–1049)[Y1049W]
GYHLMSFPQAAPHGVVFLHVTW
>15651:1: 
>15651:2: 
>6581:1:TAT(48-57)
GRKKRRQRRR
>15344:1:HCV (1975-1992)[C11R]
SWLRDIWDWIREVLSDFK
>15714:1:FIV Egp (736-770)
YNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKW
>15190:1:
IEEIYKKIEEIYKKIEEIYKKIEEIYKKIEEIYKKXK
>5895:1:EBR26
LFYLVPGPGHG
>6610:1:P97, GBV-C E2 (289-306)
LVRRRSELMGRRNPVCPG
>15485:1:MTSC29EK
MTWEEWDKKIEEYTKKIEELIKKSEEQQKKN
>2983:1:Circulin-D
KIPCGESCVWIPCVTSIFNCKCENKVCYHD
>15256:1:
KKKKLLAAFLFFF
>15743:1:LP-46
WQEWEQKITALLEQAQIQQEKNEYELQKLDKX
>15313:1:MHV-S (1216-1254)
DLSLDFEKLNVTLLDLTYEMNRIQDAIKKLNESYINLKE
>6186:1:
LQQLLFIHFRIARRRRRRRR
>15554:1:Alloferon [H1W]
WGVSGHGQHGVHG
>15411:1:BVDV gp (2697-2714)
VLDLIYSLHKQINRGLKK
>5102:1:Defensin2-Ir, Def2-Ir
GGYYCPFRQDKCHRHCRSFGRKAGYCGGFLKKTCICV
>6684:1:
HCAFWW
>15738:1:LP-73
VEELEKKIEELLKKAEEQQKKNEEELKKLEX
>15368:1:HCV gp (710-723)
VSFAIKWEYVLLLF
>15692:1:RSV Fgp (497-515)[F9A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSLXAIXKSDXLLHNV
>6407:1:
KIEEIESKIKKIENEIARIKKLLQLTVWGIKQLQARIL
>6057:1:Caerin-3.2 (1-13)[K7D,E8K,K9F,E12I,L13I]
GLWEKIDKFASII
>16544:1:(ARG)8
wrrrrrrrrG
>6112:1:LEDGF (361-370)[L363A]
WNSAKIDNLDV
>15387:1:MERS-S (1257-1286)
TTLLDLTYEMLSLQQVVKALNESYIDLKEL
>17210:1:ACE2 (24-36)
QAKTFLDKFNHEA
>15503:1:DET2
PWLKPGDLDL
>15153:1:EK1P
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL
>15850:1:Sifuvirtide
SWETWEREIENYTRQIYRILEESQEQQDRNERDLLE
>15446:1:GBV-A10 [C1K,Y8K,T15K,T18K]
KWVRLGRKLLRRLKKPFK
>13711:1:Human Defensin-5, HD5 [S23R]
ATCYCRTGRCATRESLSGVCEIRGRLYRLCCR
>6000:1:HIV-1 RT (514-528)
ESELVSQIIEQLIKK
>13341:1:D3A15
KRKRFAKKFLRFLRKVIRFLKRFIRRF
>15295:1: 
>15295:2: 
>7754:1:
HRILMRIAQMMT
>15780:1:Claudin-1 (11-28)
FILAFLGWIGAIVSTALP
>7304:1:MU103
RRRRRRRWWWRRRRRRRR
>6515:1:C41 [E18X]
EWDREINNYTSLIHSLIXESQNQQEKNEQELLELDKWASLW
>5905:1:EBR28 [Y9A]
YQLLIRMIAKNI
>15515:1: 
>15515:2: 
>15450:1:HCV gp (548–562), E2-42
QGSWFGCTWMNSTGF
>6295:1:Reverse D IN (129-139)
feqkiGawwca
>15779:1:Claudin-1 (8-25)
LLGFILAFLGWIGAIVST
>15283:1:SARS-Cov-S (916-950)
IQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSS
>15329:1:HCV (1975-1994)
SWLRDIWDWICEVLSDFKTW
>6446:1:
WMEWDRKIEEYTKKIKKLIEESQEQQEKNEKELK
>6016:1:
AEAMSQV
>11385:1:Cyclic Protegrin 1, Cyclic PG-1
RGGRLCYCRRRFCVCVGR
>6153:1:
RILQQLLFIHFRIGRRRRRRRR
>15796:1:Claudin-9 (1-18)
MASTGLELLGMTLAVLGW
>15542:1:Alloferon [H1F]
FGVSGHGQHGVHG
>5401:1:Neutrophil defensin 2, HNP-2
CYCRIPACIAGERRYGTCIYQGRLWAFCC
>5952:1:Vif (88-98)
EWRKKRYSTQV
>4640:1:NS5A-derived peptide C5A [I10A]
SWLRDIWDWACEVLSDFK
>6387:1:
IEAQQHLLQLTVWGIKQLQARIL
>15407:1:YFV gp (3328-3345)
WVLNNPHMKDKTTVKEWR
>16552:1:Myrist-(ARG)8
wrrrrrrrrG
>15684:1:RSV Fgp (497-515)[N4A;A8,K12,E15,N19 -S-ALA-4-pen]
EKIAQSLXFIRXSDXLLHXV
>15391:1:apoE (131-162), hEP-2/delC
EELRVRLASHLRKLRKRLLRDADDLQKRLAVY
>6554:1:N27 -C16 
RQLLSGIVQQQNNLLRAIEAQQHLLQK
>16553:1:Palmit-(ARG)8
wrrrrrrrrG
>15685:1:RSV Fgp (497-515)[R11A;A8,K12,E15,N19 -S-ALA-4-pen]
EKINQSLXFIAXSDXLLHXV
>15390:1:C-apoE (131-162), hEP-2
CEELRVRLASHLRKLRKRLLRDADDLQKRLAVY
>6105:1:
TTWEAWDRAIAEYAARIEALIRALQELQEKNEAILREL
>6555:1:N25
RQLLSGIVQQQNNLLRAIEAQQHLL
>15543:1:T20 [H6R; S7E; L8,26I; I9L; E10V; Q13,21R; N14I; L24R; E25D]
YTSLIREILVESRIQQEKNERELRDIDKWASLWNWF
>5953:1:Vif (30-37)
YVSGKARG
>4641:1:NS5A-derived peptide C5A [I10G]
SWLRDIWDWGCEVLSDFK
>6386:1:
LLQLTVWGIKQLQARIL
>15406:1:DENV-1 gp (2949-2966)
KREKKLGEFGKAKGSRAI
>15778:1:Claudin-1 (5-22)
GLQLLGFILAFLGWIGAI
>15282:1:SARS-Cov-S (899-926)
YENQKQIANQFNKAISQIQESLTTTSTA
>15328:1:HCV (1975-1993)
SWLRDIWDWICEVLSDFKT
>6447:1:
WXEWDRKIEEYTKKIEELIKKSQEQQEKNEKELK
>6017:1:
AEAMSQ
>6152:1:
ILQQLLFIHFRIGRRRRRRRR
>5904:1:EBR28 [I8A]
YQLLIRMAYKNI
>15514:1:DENV-2 gp (662-674)
VEPGQLKLNWFKK
>15451:1:HCV gp (552–566), E2-43
FGCTWMNSTGFTKTC
>564:1:Drosocin, Drosocin-1
GKPRPYSPRPTSHPRPIRV
>6294:1:Reverse IN (129-139)
FEQKIGAWWCA
>13710:1:Human Defensin-5, HD5 [E21R]
ATCYCRTGRCATRESLSGVCRISGRLYRLCCR
>13340:1:D5C
 KRKRAVKRVGRRLKKKLARKIARLGVAF
>15294:1:SARS-CoV-S (1161-1180)
IQKEIDRLNEVAKNLNESLI
>7755:1:
HRILMRIRAMMT
>15781:1:Claudin-1 (14-31)
AFLGWIGAIVSTALPQWR
>7305:1:MU104
RRRRRRRRRRRRRRRWWW
>6514:1:C41 [E18X]
EWDREINNYTSLIHSLIXESQNQQEKNEQELLELDKWASLW
>15502:1:
EF
>15152:1:EK1
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL
>15851:1:MT-Sifuvirtide
MTWETWEREIENYTRQIYRILEESQEQQDRNERDLLE
>15447:1:GBV-A10 [Y8K]
CWVRLGRKLLRRLKTPFT
>15739:1:LP-74
WEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEX
>15369:1:HCV gp (710-722)
VSFAIKWEYVLLL
>15693:1:RSV Fgp (497-515)[I10A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSLXFAXKSDXLLHNV
>16545:1:Octa-(ARG)8
wrrrrrrrrG
>6056:1:Enfuvirtide, ENF, T-20, Fuzeon, DP-178
YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF
>15386:1:MT-WQ-IDL-scrambled
EEQKTQLKNKIEIDWTKMELEQDWSKIYKEI
>17211:1:ACE2 (37-42)
EDLFYQ
>6390:1:
RMKQIEDKIEEIESKQKKIENEIARIKKLIGERY
>15555:1:Alloferon [H1Phe-Gly]
XGVSGHGQHGVHG
>15410:1:GBV-C gp (1872-1889)
LWEWIMRQVRMVMSRLRA
>6538:1:C12- N27
RQLLSGIVQQQNNLLRAIEAQQHLLQK
>2982:1:Circulin-C
GIPCGESCVFIPCITSVAGCSCKSKVCYRN
>15257:1:
KKKKLVLPFLFVF
>15742:1:LP-19
EMTWEEWEKKVEELEKKIEELLXX
>15312:1:SARS-CoV-S (1134-1185)
ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL
>15191:1:
IEEIWKKIEEIWKKIEEIWKKIEEIWKKIEEIWKKXK
>5894:1:LCD278C
QLLIRMIYKNI
>6241:1:IN (97-108)[L8A]
TAYFLLKAAGRW
>6611:1:P109, GBV-C E2 (325-342)
LQEVDAGNFIPPPRWLLL
>15484:1:MTSC30EK
MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNE
>15200:1:SARS-CoV (864-886)
ATAGWTFGAGAALQIPFAMQMAY
>15650:1: 
>15650:2: 
>15345:1:HCV (1975-1992)[C11E]
SWLRDIWDWIEEVLSDFK
>15715:1:FIV Egp (737-771)
NQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKWE
>5986:1:Caps-WT
APKEWMEWDREINNYTSLIHSLIKQGI
>159:1:Cathelicidin-6 (1-15)
GRFKRFRKKFKKLFK
>15596:1:Pa-MAP 1.7, Antifreeze peptide analogue
LKAALTAAKTALTAALTALKAALTAAKT
>2255:1:D76, DASamP1, Temporin-PTa [S4K][P10R][L13F]
FFGKVLKLIRKIF
>15646:1:SARS-CoV Sgp (737–756)[T743A,A754V]
QYGSFCAQLNRALSGIAVEQ
>16969:1:SARS-CoV-2-S (1179-1205), IPB05
IQKEIDRLNEVAKNLNESLIDLQELGK
>15216:1:MBD-4 (11-40), P9
NGAICWGPCPTAFRQIGNCGHFKVRCCKIR
>15703:1:RSV Fgp (488-522)[A3,R20- R-ALA-7-oct;E10,H27- S-ALA-4-pen]
FDXSISQVNXKINQSLAFIXKSDELLXNVNAGKST
>15353:1:SARS-S (946-981)
KQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITG
>18561:1:Scopularide A
AFXGVl
>8072:1:Secreted protein C10orf99
KRRPAKAWSGRRTRLCCHRVPSPNSTNLKGHHVRLCKPCKLEPEPRLWVVPGALPQV
>18998:1:Plitidepsin, Aplidine
PxTXXLPX
>5569:1:Piscidin 3
FIHHIFRGIVHAGRSIGRFLTG
>17047:1:MERS-CoV-HR2P-GSGSGC
SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKELGSGSGC
>2306:1:D98, Temporin-LTc-3r, Temporin-LTc [S7R][P14R][P15R]
SLSRFLRFLKIVYRRAF
>15241:1:
AKDLEVVCSTYVLVEA
>7295:1:
RWWRWWRRWWRWWR
>15611:1:LP-50
YTSLIEELIKKSEEQQKKNEEELKKLEX
>15304:1: 
>15304:2: 
>15304:3: 
>15754:1:P-70
INNYTSLIEELIKKSEEQQKKNEEELKKLEK
>15187:1:
YEEYSKKYEEYSKKYEEYSKKYEEYSKKYEEYSKKXK
>15538:1:Alloferon (1-11)
HGVSGHGQHGV
>15168:1:MERS-CoV-HR2P
SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL
>15492:1:MTSC22EK
MTWEEWDKKIEEYTKKIEELIKKS
>5928:1:Vif (59-74)
LGDARLVITTYWGLHT
>6607:1:P47, GBV-C E2 (139-156)
VELSEWGVPCATCILDRR
>6220:1:IN (139-148)
FGIPYNPQSQ
>6670:1:12p1
RINNIPWSEAMM
>37:1:PGLa
GMASKAGAIAGKIAKVALKAL
>6735:1:BMAP-18
GRFKRFRKKFKKLFKKIS
>15723:1:LP-57
WEQKIEELLKKAEEQQKKNEEEX
>15373:1:HCV gp (710-725)
VSFAIKWEYVLLLFLL
>15689:1:RSV Fgp (497-515)[Q5A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXASLXFIXKSDXLLHNV
>616:1:Dermaseptin S4 (5-28)
TLLKKVLKAAAKAALNAVLVGANA
>6559:1:Envelope glycoprotein gp160 (555-576), N22
SGIVQQQNNLLRAIEAQQHLLQ
>6109:1:LEDGF (361-370)[N361A]
WASLKIDNLDV
>15666:1:LP-79
WEQKIEELLKKAEEQQKKNEEELKKLEX
>15236:1:MERS-S (1260-1280) [Q12,A16Ala-4-pen; Y21F]
LDLTYEMLSLQXVVKXLNESF
>15518:1:KP [A1K], K10S
KKVTMTCSAS
>5908:1:EBR28 [I12A]
YQLLIRMIYKNA
>6627:1:Enfuvirtide [S138A], T-20 [S138A]
YTSLIHSLIEEAQNQQEKNEQELLELDKWASLWNWF
>6277:1:
IKQEF
>6298:1:Vpr-1
LQQLLF
>991:1:Dermaseptin-1, DS I, Dermaseptin-S1, DS1
ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ
>15324:1:HCV (1975-1987)
SWLRDIWDWICEV
>15261:1:PEDV-S HR2, PCov-S HR2
LKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWL
>354:1:[RLLR]5
RLLRRLLRRLLRRLLRRLLR
>6261:1:IN (97-108)[Y2S]
TASFLLKLAGRW
>6631:1:Enfuvirtide [S138M], T-20 [S138M]
YTSLIHSLIEEMQNQQEKNEQELLELDKWASLWNWF
>2367:1:Lycotoxin I, M-lycotoxin-Hc1a
IWLTALKFLGKHAAKHLAKQQLSKL
>15298:1: 
>15298:2: 
>15332:1:BVDV (2697-2717)
VLDLIYSLHKQINRGLKKIVL
>6518:1:C41 [Q29X]
EWDREINNYTSLIHSLIEESQNQQEKNEXELLELDKWASLW
>7759:1:
LMRIRQMMT
>15277:1:Caerin 1.1 [E23K,H24L,L25H]
GLLSVLGSVAKHVLPHVVPVIAKLH
>15559:1:Eval418-FH2
LWGHIWNFVHGLI
>3937:1:Hepcidin TH2-3
QSHLSLCRWCCNCCRSNKGC
>6723:1:
PLCVNCWPQVCGDFPWGAVA
>6373:1:
WFVLLTITVLR
>7098:1:RTD-2, Theta defensin 2 [L15I]
GVCRCLCRRGVCRCICRR
>16549:1:Deca-(ARG)9
wrrrrrrrrrG
>15365:1:HCV gp (715-725)
KWEYVLLLFLL
>15735:1:LP-70
INNYTSLIEELIKKSEEQQKKNEEELKKLEX
>15220:1:MERS-S (1260-1280) [T4,L8Ala-4-pen]
LDLXYEMXSLQQVVKALNESY
>15670:1:LP-89
KIEELLKKAEEQQKKNEEELKKLEX
>4572:1:Kn2-7
FIKRIARLLRKIF
>102:1:Dermaseptin S4 [M4K][N20K] 
ALWKTLLKKVLKAAAKAALKAVLVGANA
>15467:1:SC30EK
WEEWDKKIEEYTKKIEELIKKSEEQQKKNE
>3809:1:Retrocyclin-2, RC-100b
GICRCICGRRICRCICGR
>15522:1:Fibrinogen alpha chain (21-35), D15R
DSGEGDFLAEGGGVR
>15172:1:HCoV-OC43-HR2P
SLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLKDI
>15488:1:MTSC26EK
MTWEEWDKKIEEYTKKIEELIKKSEEQQ
>5932:1:Caerin 1.19
GLFKVLGSVAKHLLPHVAPIIAEKL
>9012:1:Pa-MAP2, Antifreeze peptide analogue 2
LKAAAAAAKLAAKAAKAALKAAAAAAKL
>5898:1:EBR28 [Q2A]
YALLIRMIYKNI
>6164:1:
EEIIRKLQQLLFIHFRIGRRRRRRRR
>6534:1:N27
RQLLSGIVQQQNNLLRAIEAQQHLLQK
>6021:1:
AEAMSQVTNTATIM
>15430:1:(T21N23)3 
>15430:2:(T21N23)3 
>15430:3:(T21N23)3 
>505:1:Caerin-1.10
GLLSVLGSVAKHVLPHVVPVIAEKL
>5965:1:VMI 7
SNQGGSPLPRSV
>17118:1:D6R
rrrrrr
>6099:1:
TTWEAWDRAIAEYAARIEALIRAAQELQEKNEAALREL
>6563:1:
HQTLSGIDQEQNNLTRLIEAQIHELQK
>16973:1:SARS-CoV-2-S (1175-1198)-K, IPB09
SVVNIQKEIDRLNEVAKNLNESLIK
>12199:1:Cycloviolin D
GFPCGESCVFIPCISAAIGCSCKNKVCYRN
>15719:1:LP-53
YTSLIHSLIEESQNQQEKNEQELLEX
>15349:1:HCV (1975-1992)[D8,16R;E12K]
SWLRDIWRWICKVLSRFK
>6426:1:
KPFVFLM
>13337:1:D2B15
 GAKKGAKKGKKGAKKGAKGAGAKGAGAFKKKK
>1526:1:Nigrosin-OG13 
GLLSGILGAGKHIVCGLSGLR
>143:1:LL-37 (9-29)
SKEKIGKEFKRIVQRIKDFLR
>15426:1:T21N23
RIQQIEQKIHHIEQRIQQIEQRAIEAQQHLLQLTVWGIKQLQARIL
>15563:1:Defensin BmKDfsin4
GFGCPFNQGQCHKHCQSIRRRGGYCDGFLKTRCVCYR
>2536:1:Kalata-B8
GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD
>16965:1:MBD-4 (11-40) / P9 [H21R,K23R,K28R], P9R
NGAICWGPCPTAFRQIGNCGRFRVRCCRIR
>6575:1:
SGIDQEQNNLTRLIEAQIHELQLTQWKIKQLLARILK
>6060:1:
MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELL
>15471:1:SC26EK
WEEWDKKIEEYTKKIEELIKKSEEQQ
>1121:1:Beta-defensin 4A, Beta-defensin 2, BD-2, hBD-2, SAP1
GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP
>19002:1:Brevinin family peptide Yodha 
SMLLLFFLGTISLSLCQDDQERC
>5924:1:Vif (30-44)
YVSGKARGWFYRHHY
>4636:1:NS5A-derived peptide C5A [I6L,V13L]
SWLRDLWDWICELLSDFK
>15164:1:SARS-CoV-2-S(1168–1203)
DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL
>15534:1:Alloferon (7-13)
GQHGVHG
>6522:1:C41 -X
EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWX
>6172:1:
EAEIRIKQQLLFIHFRIGRRRRRRRR
>7299:1:
YRWWRWARRW
>7763:1:
hrilmrirqmmt
>15758:1:P-74
WEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEK
>15308:1:SARS-CoV (1130-1189)[F1P]
PKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE
>6037:1:
MHGQVDCSPGIWQLD
>15180:1:Mucroporin (13-17)
VSAFK
>6315:1:Cathelicidin-4 / Indolicidin (1-12)[R12P]
ILPWKWPWWPWP
>6600:1:P19, GBV-C E2 (55-72)
LPAFCQAIGWGDPITHWS
>6250:1:IN (129-139)[C2A]
AAWWAGIKQEF
>15495:1:MTSC19EK
MTWEEWDKKIEEYTKKIEELI
>6179:1:
LQQLAFIHFRIGRRRRRRRR
>7292:1:
RRWYRWWR
>2090:1:Apidaecin-1A
GNNRPVYIPQPRPPHPRI
>15246:1:
DDSVVSAAMSYSYA
>15616:1:LP-86
LEANIEELLKKAEEQQKKNEEELKKLEKC
>15303:1: 
>15303:2: 
>15303:3: 
>18531:1:Penilumamide A
XXX
>15753:1:P-65
IEELLKKAEEQQKKNEEELKKLEK
>5997:1:HIV-1 RT (171-185)
FRKQNPDIVIYQYMD
>148:1:
GFKRIVQRiKDFLRNLV
>6712:1:P6-2
LCDCPNGPWVWVPAFCQAVG
>15568:1:
KKWK
>6657:1:CCR5 ECL2 (168-179)
RSQKEGLHYTCS
>15991:1:SAH-gp41 A
XTWXEWDXEINNYTSLIHSLIEESQNQQEKNEQELLE
>15641:1:SARS-CoV Sgp (354–373)[F360S]
VLYNSTSFSTFKCYGVSATK
>15211:1:SARS-CoV (902-947)-SARS-CoV (902-947)eg 
>15211:2:SARS-CoV (902-947)-SARS-CoV (902-947)eg 
>15704:1:FIV Egp (724-758)
IWNHGNITLGEWYNQTKDLQQKFYEIIMDIEQNNV
>15354:1:SARS-S (981-1014)
GRLQSLQTYVTQQLIRAAEIRASANLAATKMSEC
>6354:1:
LL
>5981:1:Apelin-17
KFRRQRPRLSHKGPMPF
>6641:1:Enfuvirtide [S138E], T-20 [S138E]
YTSLIHSLIEEEQNQQEKNEQELLELDKWASLWNWF
>6211:1:IN (38-47)
ASCDKCQLKG
>15207:1:SARS-CoV (1153–1182)
GINASVVNIQKEIDRLNEVAKNLNESLIDL
>16978:1:SARS-CoV-2-S(1168–1203)-GSGSGC
DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGSGSGC
>15657:1: 
>15657:2: 
>15657:3: 
>15342:1:HCV (1975-1992)[I6,10V;E12T]
SWLRDVWDWVCTVLSDFK
>12487:1:Antifungal protein PAF
AKYTGKCTKSKNECKYKNDAGKDTFIKCPKFDNKKCTKDNNKCTVDTYNNAVDCD
>15712:1:FIV Egp (734-768)
EWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQ
>15196:1:HR2PM2, HR2P [T1263E;L1267K;S1268K;Q1270,1271E;A1275K;N77E]
SLTQINTTLLDLEYEMKKLEEVVKKLEESYIDLKEL
>15179:1:Mucroporin (7-17)
SLIGGLVSAFK
>15483:1:MTSC31EK
MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEK
>15529:1:ZIKV Ep (424-452)
AWDFGSVGGVFNSLGKGIHQIFGAAFKSL
>5893:1:I29
RMIYKNILFYLVPGPGHGAEPERRNIKYL
>6616:1:Rev (34-50)
TRQARRNRRRRWRERQR
>15600:1:D-HNP-4 (1-11)
vcscrlvfcrr
>15250:1:
KKKKVVKATYVLV
>2985:1:Circulin-F
AIPCGESCVWIPCISAAIGCSCKNKVCYR
>6180:1:
LQQLLAIHFRIGRRRRRRRR
>16539:1:7R-Ahx-HBV Large envelope protein (19-24)
RRRRRRRXLDPAFR
>15745:1:C34-C16
WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLX
>15315:1:ACE2 (4-13)
EEQAKTFLDK
>15552:1:T20 [H6R; S7E; E10,22S; E11,25N; S12A; Q13R; N14T; E17T; K18D; Q21E; L24R; L26V]
YTSLIRELISNARTQQTDNEESLRNVDKWASLWNWF
>15801:1:Figainin 2, Figainin-02
FLGAILKIGHALAKTVLPMVTNAFKPKQ
>871:1:Neutrophil antibiotic peptide NP-4, RatNP-4, Neutrophil defensin 4
ACYCRIGACVSGERLTGACGLNGRIYRLCCR
>15417:1:GBV-A5
LLDCWVRLGRYLLRRLK
>6401:1:
IKKEIEAIKKEQEAIKKKIEAIEKEIEAQQHLLQLTVWGIKQLQARIL
>6051:1:HIV-1 integrase (171-187)
HLKTAVQMAVFIHNFKR
>16542:1:LK-3 
>16542:2:LK-3 
>15694:1:RSV Fgp (497-515)[K12A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSLXFIXASDXLLHNV
>15381:1:WQ-LDL
WEEWDKKIEEYTKKIEELIKKSQNQQLDL
>5915:1:LCE41
YQLLIRMIY
>15856:1:BLV gp (391-419)[R403A]
CCFLRIQNDSIIALGDLQPLSQRVSTDWQ
>15505:1:DN57wt,
AWLVHTQWFLDLPLPWLPGADTQGSNWI
>15155:1:EK1C1
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL
>15440:1:GBV-A10 [G6L]
CWVRLLRYLLRRLKTPFT
>5850:1:White cloud bean defensin
MEKKSFAGLCFLFLVLFVAQECVLQTEAKTCENLADTFRGPCFATGNCDDHCKNKEHLLRGRCRDDFRCWCTRNC
>15913:1:Hecate, DP1
FALALKALKKALKKLKKALKKAL
>15339:1:HCV (1975-1992)[S1D,D5I,I10V,E12S,L14V]
DWLRIIWDWVCSVVSDFK
>10091:1:K-Dermaseptin-S1 (1-15)[W31NAL]
KALXKTMLKKLGTMAL
>15293:1:SARS-CoV-S (890-909)
GIGVTQNVLYENQKQIANQF
>6456:1:
EEYTKKIEEYTKKIEEYTKKIEEYTKKIEEYTKKI
>6513:1:C41 [S15X]
EWDREINNYTSLIHXLIEESQNQQEKNEQELLELDKWASLW
>15786:1:Claudin-1 (1-14)
MANAGLQLLGFILA
>2550:1:Defensin MGD1(21-39) peptide P
CGGYCGGWKRKRCTSYRCG
>7752:1:
HRILARIRQMMT
>15513:1:DENV-2 gp (613-627)
CKIPFEIMDLEKRHV
>5903:1:EBR28 [M7A]
YQLLIRAIYKNI
>6339:1:
KQLTEAVQKITTESIVIWGK
>11045:1:Cytotoxin 1 (5-25)[P4W,A6L,C10I,G13I,C17F,M20I], Naja Cardiotoxin Peptide NCP-3
KLIWILSKTIPAIKNLFYKI
>15456:1:IBP-CP24
DCAWHLGELVWCTMTWEEWDKKIEEYTKKIEELIKKS
>6010:1:
AEAMSQVTN
>15285:1:SARS-CoV-S (220-239)
FKLPLGINITNFRAILTAFS
>10087:1:Dermaseptin-S1 (1-29)[K4T,T12K]
ALWTTMLKKLGKMALHAGKAALGAAADTI
>15790:1:Claudin-1 (1-24)
MANAGLQLLGFILAFLGWIGAIVS
>6155:1:
IIRILQQLLFIHFRIGRRRRRRRR
>5954:1:Vif (33-40)
GKARGWFY
>11854:1:LL-37 (16-32)[E1G; F2,12BIP; I5,9l; L13l], GF-17BIPHE2
GXKRlVQRlKDXlRNLV
>15544:1:T20 [L8I; Q13,15R; E22A]
YTSLIHSIIEESRNRQEKNEQALLELDKWASLWNWF
>15401:1:C-apoE (133–155), hEP-11
CLRVRLASHLRKLRKRLLRDADDL
>18233:1:D-LL-37 (13-32)[I13G,G14I]
Gikefkrivqrikdflrnlv
>1501:1:Odorranain-K1
GLFTLIKGAAKLIGKTVPKKQARLGMNLWLVKLPTNVKT
>15378:1:WQ-SW
WEEWDKKIEEYTKKIEELIKKSQNQQSW
>15682:1:RSV Fgp (497-515)[E1R,K12 -ALA-7-oct; A8,N19 -S-ALA-4-pen]
XKINQSLXFIRXSDELLHXV
>15728:1:LP-62
EQKIEELLKKAEEQQKKNEEELKKLEX
>16554:1:Stear-(ARG)8
wrrrrrrrrG
>6102:1:
TTWEAWDRAIAEYAARIEALIRAAQEQQEKLEAVLREL
>758:1:Moronecidin, Piscidin-2 
FFHHIFRGIVHVGKTIHKLVTG
>15397:1:apoE (133–162), hEP-7
LRVRLASHLRKLRKRLLRDADDLQKRLAVY
>6175:1:
AQQLLFIHFRIGRRRRRRRR
>6030:1:Vpr (61-75)
IRILQQLLFIHFRIG
>12130:1:Alloferon-2
GVSGHGQHGVHG
>6319:1:LEDGF/p75 (355-377)
IHAEIKNSLKIDNLDVNRCIEAL
>15476:1:SC21EK
WEEWDKKIEEYTKKIEELIKK
>15163:1:SARS-CoV-HR1P
ANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQ
>15499:1:WQ-ENK
WEEWDKKIEEYTKKIEELIKKSQNQQEKN
>15533:1:Alloferon (6-13)
HGQHGVHG
>15860:1:DENV4 Ep (419-447)
AWDFGSVGGLFTSLGKAVHQVFGSVYTTM
>5923:1:Vif (30-65)
YVSGKARGWFYRHHYESPHPRISSEVHIPLGDARLV
>4631:1:NS5A-derived peptide C5A
SWLRDIWDWICEVLSDFK
>6572:1:C12- N36
SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
>16962:1:LCB1
DKEWILQKIYEIMRLLDELGHAEASMRVSDLIYEFMKKGDERLLEEAERLLEEVER
>15358:1:HCV gp (711-725)
SFAIKWEYVLLLFLL
>12167:1:Cycloviolacin O24
GLPTCGETCFGGTCNTPGCTCDPWPVCTHN
>15708:1:FIV Egp (730-764)
ITLGEWYNQTKDLQQKFYEIIMDIEQNNVQGKKGI
>6067:1:
TTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAALREL
>15421:1:GBV-A9
DCWVRLGRYLLRRLKTPF
>847:1:Temporin-B, Temporin-1Tb	
LLPIVGNLLKSLL
>144:1:LL-37 (17-29)
FKRIVQRIKDFLR
>15564:1:
KKWK
>6564:1:
HQTLSGIDQEQNNLTRLIEAQIHELQK
>13330:1:D2A21
FAKKFAKKFKKFAKKFAKFAFAF
>6071:1:
GFNEIVQDIEDFLQNLV
>152:1:LL-37 (13-32)[I13G,G14I,F17W]
GIKEWKRIVQRIKDFLRNLV
>15437:1:GBV-A10 [L9V]
CWVRLGRYVLRRLKTPFT
>5962:1:Vif (88-95)
EWRKKRYS
>6163:1:
EAIIRILQQLLFIEFRIKRRRRRRRR
>2570:1:Pv-Defensin, White cloud bean defensin
KTCENLADTFRGPCFATSNCDDHCKNKEHLLSGRCRDDFRCWCTRNC
>15319:1:ACE2 (4-39)
EEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEE
>15749:1:P-60
SLIEELIKKSEEQQKKNEEELKKLEK
>6026:1:Vpr (49-63)
TYGDTWAGVEAIIRI
>6476:1:SC29EK
WEEWDKKIEEYTKKIEELIKKSEEQQKKN
>15460:1:FCoV Sgp (1338-1373)
FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNI
>15525:1:JEV Ep (428–452)
SIGGVFNSIGRAVHQVFGGAFRTL
>15175:1:EK0-3, HCoV-OC43-HR2P [Y4Q,Q13E,D14Y,N17K,R18K,Q20E,V25K,N27,Q28E,N32D,D35E]
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEI
>15362:1:Retro-HCV gp (713-725)
LLFLLLVYEWKIA
>18550:1:Cathelicidin-4 / Indolicidin [R12P][R13P] Tetramer 
>18550:2:Cathelicidin-4 / Indolicidin [R12P][R13P] Tetramer 
>18550:3:Cathelicidin-4 / Indolicidin [R12P][R13P] Tetramer 
>18550:4:Cathelicidin-4 / Indolicidin [R12P][R13P] Tetramer 
>15698:1:RSV Fgp (497-515)[H18A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSLXFIXKSDXLLANV
>15732:1:LP-66
EELLKKAEEQQKKNEEELKKLEX
>6118:1:LEDGF (361-370)[D366A]
WNSLKIANLDV
>15227:1:MERS-S (1260-1280) [A16,S20Ala-4-pen]
LDLTYEMLSLQQVVKXLNEXY
>15677:1:Cyclosporin A
XXXVXAaXXXX
>6661:1:CCR5 ECL2 (170-189)
QKEGLHYTCSSHFPYSQYQF
>6231:1:IN (97-108)[Y3A]
TAAFLLKLAGRW
>6724:1:
IYWNVSGW
>4349:1:Dermaseptin-S9
GLRSKIWLWVLLMIWQESNKFKKM
>6374:1:
WQSLTLTHRG
>1665:1:Defensin-like protein, Coccinin
KQTENLADTY
>15335:1:HCV (1975-1992) scrambled
KWLCRIWSWISDVLDDFE
>15620:1:C34-Chol
WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLGSGC
>15270:1:Surfactin-like peptide SLP6
KVlKl
>15159:1:EK1C5
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG
>15509:1:DN81opt
RQMRAWGQDYQHGGMGYSC
>6266:1:IN (129-139)[W4G]
ACWGAGIKQEF
>5919:1:C35
LSELDDRADALQAGASQFETSAAKLKRKYWWKN
>6289:1:D IN (97-108)
tayfllklaGrw
>15323:1:HCV (1975-1988)
SWLRDIWDWICEVL
>15289:1:SARS-CoV-S (553-572)
RDVSDFTDSVRDPKTSEILD
>6509:1:C41 [R4X]
EWDXEINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW
>7748:1:
HRILMRIRQMMT
>4867:1:Piscidin 1, Moronecidin
FFHHIFRGIVHVGKTIHRLVTG
>15266:1:Surfactin-like peptide SLP2
EVlDlV
>12409:1:Smp76
GWINEKKMQQKIDEKIGKNIIGGMAKAVIHKMAKNEFQCVANVDTLGNCKKHCAKTTGEKGYCHGTKCKCGIELSY
>15636:1:
HVTTTFAPPPPR
>6620:1:Rex (1-21) -RTD
MPKTRRRPRRSQRKRPPTPWPYGRKKRRQRRR
>611:1:Dermaseptin S4 [M4K] 
ALWKTLLKKVLKAAAKAALNAVLVGANA
>15724:1:LP-58
WEQKIEELLKKAEEQQKKNEX
>15661:1:
VNKKIEEIDKKIEELNKKLEELEKKLEEVNKK
>15231:1:MERS-S (1260-1280) [Q12,A16Ala-4-pen]
LDLTYEMLSLQXVVKXLNESY
>15548:1:Alloferon [H1Y]
YGVSGHGQHGVHG
>1018:1:Ranatuerin-9
FLFPLITSFLSKVL
>5958:1:Vif (58-65)
PLGDARLV
>6677:1:
HCKFWF
>15549:1:T20 [I5L, H6W, L8I, S12G, Q13R, Q15L, E22K]
YTSLLWSIIEEGRNLQEKNEQKLLELDKWASLWNWF
>6226:1:IN (260-267)
VPRRKAKI
>5959:1:Vif (78-85)
DWHLGQGV
>15725:1:LP-59
WEQKIEELLKKAEEQQKX
>15375:1:WQ
WEEWDKKIEEYTKKIEELIKKSQNQQ
>17348:1:Antifungal protein PAFB
KFGGECSLKHNTCTYLKGGKNHVVNCGSAANKKCKSDRHHCEYDEHHKRVDCQTPV
>15660:1:
VNKKIEEIDKKIEELNKKLEELEKKLEEVNKK
>15230:1:MERS-S (1260-1280) [L8,Q12Ala-4-pen]
LDLTYEMXSLQXVVKALNESY
>755:1:Circulin-A, CIRA
GIPCGESCVWIPCISAALGCSCKNKVCYRN
>6621:1:RCG-P2G4
RPRGRRGSRPSGAERRRRRAAAA
>6271:1:
KLAGRW
>8795:1:Pa-MAP, Antifreeze peptide analogue
HTASDAAAAAALTAANAAAAAAASMA
>15322:1:HCV (1975-1990)
SWLRDIWDWICEVLSD
>15288:1:SARS-CoV-S (470-489)[T487S]
PALNCYWPLNDYGFYTTTGI
>6508:1:C41 [R4X]
EWDXEINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW
>15267:1:Surfactin-like peptide SLP3
EVlDl
>7749:1:
ARILMRIRQMMT
>15637:1:
SVVPSKATWGFA
>15158:1:EK1C4
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG
>15508:1:DN81wt
AWLVHRQWFLDLPLPWLPG
>6267:1:IN (129-139)[K8R]
ACWWAGIRQEF
>6637:1:Enfuvirtide [S138W], T-20 [S138W]
YTSLIHSLIEEWQNQQEKNEQELLELDKWASLWNWF
>5918:1:EBR28 [M7P]
YQLLIRPIYKNI
>18506:1:Dominicin
IIILPPXP
>5627:1:Pardaxin P-4
GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE
>15334:1:D-Retro-HCV (1975-1992)
kfdslveciwdwidrlws
>10589:1:Modified Clavanin A
FLPIIVFQFLGKIIHHVGNFVHGFSHVF
>15271:1:Surfactin-like peptide SLP7
EVLDL
>6230:1:IN (97-108)[T1A]
AAYFLLKLAGRW
>15363:1:D-Retro-HCV gp (713-725)
llflllvyewkia
>15699:1:RSV Fgp (497-515)[N19A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSLXFIXKSDXLLHAV
>15733:1:LP-67
LLEQAEEQQKKNEEELKKLEX
>606:1:Dermaseptin S4
ALWMTLLKKVLKAAAKAALNAVLVGANA
>6119:1:LEDGF (361-370)[N367A]
WNSLKIDALDV
>15226:1:MERS-S (1260-1280) [K15,E19Ala-4-pen]
LDLTYEMLSLQQVVXALNXSY
>16959:1:ATN-161
PHSCN
>15461:1:FCoV Sgp (1338-1380)
FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNL
>15524:1:JEV Ep (401–428)
STLGKAFSTTLKGAQRLAALGDTAWDFG
>15174:1:EK0-2, HCoV-OC43-HR2P [Q13E,N17K,R18K,Q20E,V25K,N27,Q28E,D35E]
SLDYINVTFLDLEDEMKKLEEAIKKLEESYINLKEI
>2571:1:AB2, red bean antifungal peptide, Putative defensin 3.1
ATCENLANTYRGPCFGGCDFHCKTKEHLLSGRCRDDFRCWCTRNC
>15318:1:ACE2 (4-26)
EEQAKTFLDKFNHEAEDLFYQSS
>15748:1:P-55
WEQKIEELLKKAEEQQKKNEEELKK
>6027:1:Vpr (33-47)
HFPRIWLHSLGQHIY
>3225:1:Antimicrobial peptide 1, Cn-AMP1
SVAGRAQGM
>6477:1:C34
WMEWDREINNYTSLIHSLIEESQNQQEKNEQELL
>1648:1:Neutrophil defensin 4, Defensin alpha 4, HNP-4 
VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV
>153:1:LL-37 (13-32)[I13G,G14I,E16Q]
GIKQFKRIVQRIKDFLRNLV
>6709:1:P4-7
WDRGNVTLLCDCPNGPWVWV
>15436:1:GBV-A10 [L9A]
CWVRLGRYALRRLKTPFT
>16975:1:SARS-CoV-2-S(1168–1203)-GSGSGC
DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGSGSGC
>6565:1:
RQLLSGIDQEQNNLTRLIEAQIHELQK
>13331:1:D4E1
FKLRAKIKVRLRAKIKL
>6070:1:LL-37 (15-32)[E1G], GF-17
GFKRIVQRIKDFLRNLV
>15420:1:GBV-A8
LDCWVRLGRYLLRRLKTP
>145:1:
RLFDKIRQVIRKF
>2249:1:Metalnikowin-1 
VDKPDYRPRPRPPNM
>15565:1:
XXWX
>6123:1:LEDGF (361-370)[V370A]
WNSLKIDNLDA
>6573:1:C16- N36
SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
>16963:1:LCB3
NDDELHMLMTDLVYEALHFAKDEEIKKRVFQLFELADKAYKNNDRQKLEKVVEELKELLERLLS
>15359:1:HCV gp (712-725)
FAIKWEYVLLLFLL
>15709:1:FIV Egp (731-763)
TLGEWYNQTKDLQQKFYEIIMDIEQNNVQGKKG
>6066:1:
TTWEAWDRAIAEYAARIEALIRASQEQQEKNEAELREL
>6318:1:Cathelicidin-4 / Indolicidin [P3,7,10A][R12,13P] 
ILAWKWAWWAWPP
>1824:1:Maculatin-1.1
GLFGVLAKVAAHVVPAIAEHF
>15477:1:SC20EK
WEEWDKKIEEYTKKIEELIK
>15162:1:EK1-scrambled
LKVLLYEEFKLLESLIMEILEYQKDSDIKENAEDTK
>15498:1:MT-WQ-IDL
MTWEEWDKKIEEYTKKIEELIKKSQNQQIDL
>15532:1:Alloferon (5-13)
GHGQHGVHG
>15861:1:DENV1 Ep (419-447)
AWDFGSIGGVFTSVGKLVHQVFGTAYGVL
>5922:1:Vif (17-29)
RIRTWKSLVKHHM
>6524:1:C41 [S20X]
EWDREINNYTSLIHSLIEEXQNQQEKNEQELLELDKWASLW
>6174:1:
EEIIRKLQQLLFIEFRIKRRRRRRRR
>6461:1:Human ApoE apolipoprotein derived peptide ApoEdpL-W
WRKWRKRWWWRKWRKRWW
>6031:1:Vpr (65-79)
QQLLFIHFRIGCQHS
>15379:1:WQ-SY
WEEWDKKIEEYTKKIEELIKKSQNQQSY
>15683:1:RSV Fgp (497-515)[N4,A8,N19 -S-ALA-4-pen; K12R-ALA-7-oct]
EKIXQSLXFIRXSDELLHXV
>15729:1:LP-63
QKIEELLKKAEEQQKKNEEELKKLEX
>16555:1:Deca-(Arg-Lys) 4–4
rrrrkkkkG
>6103:1:
TTWEAWDRAIAEYAARIEALIRALQELQEKNEAALREL
>6553:1:C16- N27
RQLLSGIVQQQNNLLRAIEAQQHLLQK
>759:1:Neutrophil defensin 1, HNP-1
ACYCRIPACIAGERRYGTCIYQGRLWAFCC
>15396:1:apoE (135–155) + (250–269), hEP-6
VRLASHLRKLRKRLLRDADDLIRLQAEAFQARLKSWFEPLV
>5955:1:Vif (37-44)
GWFYRHHY
>15545:1:T20 [I5L, H6R, L8I; S12G; Q13R; E22A]
YTSLLRSIIEEGRNQQEKNEQALLELDKWASLWNWF
>15400:1:C-apoE (135–162), hEP-10
CVRLASHLRKLRKRLLRDADDLQKRLAVY
>18232:1:LL-37 (13-32)[I13G,G14I]
GIKEFKRIVQRIKDFLRNLV
>6011:1:
AAAMSQVTN
>15284:1:SARS-Cov-S (1145-1192)
DVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI
>15791:1:D-Claudin-1 (1-18)
manaGlqllGfilaflGw
>6504:1:C41
EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW
>6154:1:
IRILQQLLFIHFRIGRRRRRRRR
>15512:1:DENV-2 gp (376-388)
MVDRGWGNGCGLF
>5902:1:EBR28 [R6A]
YQLLIAMIYKNI
>6292:1:D IN (129-139)
acwwaGikqef
>15457:1:IBP
DCAWHLGELVWCT
>15338:1:HCV (1975-1992)[I6,10V;E12T;V13I;S15T]
SWLRDVWDWVCTILTDFK
>10090:1:Dermaseptin-S1 (1-15)[W3H]
ALHKTMLKKLGTMAL
>15292:1:SARS-CoV-S (737-756)
QYGSFCTQLNRALSGIAAEQ
>6457:1:
WMEWDREIEEYTKKIEEYTKKIEEYTKKIEEYTKKI
>1687:1:Human Defensin-5, HD5
ATCYCRTGRCATRESLSGVCEISGRLYRLCCR
>6512:1:C41 [S15X]
EWDREINNYTSLIHXLIEESQNQQEKNEQELLELDKWASLW
>15787:1:Claudin-1 (1-16)
MANAGLQLLGFILAFL
>7753:1:
HRILMRARQMMT
>15504:1:DET4
AGVKDGKLDF
>15154:1:EK1C
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL
>15441:1:GBV-A10 [G6L,P16L]
CWVRLLRYLLRRLKTLFT
>15912:1:HD5 [L16R]
ATCYCRTGRCATRESRSGVCEISGRLYRLCCR
>16543:1:CT105
MTWCDWRDEIERYTKKIEELIRAAQEKNEAALKEL
>6050:1:HIV-1 integrase (123-133)
STTVKAASWWA
>15695:1:RSV Fgp (497-515)[S13A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSLXFIXKADXLLHNV
>15380:1:WQ-SDLD
WEEWDKKIEEYTKKIEELIKKSQNQQSDLD
>15553:1:T20 [H6W; L8I; E10I; E11,25D; S12G; Q13R; N14E; E17R; K18D; Q21G; E22V; L24A]
YTSLIWSIIIDGREQQRDNEGVLADLDKWASLWNWF
>4201:1:Epinecidin-1 (22-42)
GFIFHIIKGLFHAGKMIHGLV
>6396:1:
RMKQIEDKIEEIESKQKKIENEIARIKKLISGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
>6683:1:
HAKFWW
>15416:1:GBV-A4
LLDCWVRLGRYLLRRLKTP
>15601:1:D-HD5 (1-9)
atcycrtGr
>15251:1:
AECVVSCSMSYTKA
>734:1:Kalata-B1 
GLPVCGETCVGGTCNTPGCTCSWPVCTRN
>2984:1:Circulin-E
KIPCGESCVWIPCLTSVFNCKCENKVCYHD
>6181:1:
LQQLLFAHFRIGRRRRRRRR
>16538:1:7R-Ahx-HBV Large envelope protein (96-116)
RRRRRRRXPLSPPLRNTHPQAMQWNSTTF
>15744:1:LP-48
WEQKITALLEQAQIQQEKNEYELQKLDKX
>15314:1:SARS-CoV-S (935-980)
NQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLIT
>15197:1:
IEEIQKKIEEIQKKIEEIQKKIEEIQKKIEEIQKKXX
>15482:1:MTSC32EK
MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEKE
>15528:1:JEV Ep (424–445)
AWDFGSIGGVFNSIGRAVHQVF
>6617:1:Rev (34-50) -A4C
TRQARRNRRRRWRERQRAAAAC
>6569:1:N36
SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
>15206:1:MHV (1144–1162)
GYFVQDDGEWKFTGSSYYY
>16979:1:[SARS HRC-PEG4]2-chol 
>16979:2:[SARS HRC-PEG4]2-chol 
>15656:1: 
>15656:2: 
>15656:3: 
>15343:1:HCV (1975-1992)[C11S]
SWLRDIWDWISEVLSDFK
>15713:1:FIV Egp (735-769)
WYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQK
>6586:1:
RRRRRRRRRR
>6355:1:
LE
>6640:1:Enfuvirtide [S138D], T-20 [S138D]
YTSLIHSLIEEDQNQQEKNEQELLELDKWASLWNWF
>6210:1:IN (10-19)
EEHEKYHSNW
>2253:1:D74, DASamP2, Polybia-MPI [D2K][D8R][Q12R]
IKWKKLLRAAKRIL
>15640:1:SARS-CoV Sgp (259–278([T261K]
PTKFMLKYDENGTITDAVDC
>15210:1:SARS-CoV (902-947)[K2N,I4S,N9Q,A11E,Q16N,S18V,S23N,A25S,V32D,A37N,A39S,V44Q,Q46E]
QNQSANQFQKEISQINEVLTTTNTSLGKLQDDVNQNNQSLNTLQKE
>15705:1:FIV Egp (725-759)
WNHGNITLGEWYNQTKDLQQKFYEIIMDIEQNNVQ
>15355:1:SARS-S (1163-1199)
KEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYVW
>5996:1:HIV-1 RT (526-545)
IKKEKVYLAWVPAHKGIGN
>149:1:
GFKRIVQRiKDFlRNLV
>2300:1:Ascaphin-8
GFKDLLKGAAKALVKTVLF
>15569:1:
NKKN
>5979:1:Apelin-36
LVQPRGPRSGPGPWQGGRRKFRRQRPRLSHKGPMPF
>6656:1:CCR5 ECL2 (168-191)
RSQKEGLHYTCSSHFPYSQYQFWK
>15990:1:T649v
XTWXEWDREINNYTSLIHSLIEESQNQQEKNEQELLE
>6178:1:
LQQALFIHFRIGRRRRRRRR
>7293:1:
RRWYRWWRRRWYRWWR
>15247:1:
KKKKVTAATYVLV
>15617:1:LP-93
WEQKIEELLKKAEEQQKKNEEELKK
>15302:1: 
>15302:2: 
>15302:3: 
>18530:1:Penilumamide B
XMX
>15752:1:P-64
KIEELLKKAEEQQKKNEEELKKLEK
>15181:1:HKU4-HR2P1 (1247-1282)
GPNFAEISKINTTLLDLSDEMAMLQEVVKQLNDSYI
>6314:1:Cathelicidin-4 (2-13)[R12P][R13P], Indolicidin (2-13)[R12P][R13P]
LPWKWPWWPWPP
>6601:1:P20, GBV-C E2 (58-75)
FCQAIGWGDPITHWSHGQ
>15494:1:MTSC20EK
MTWEEWDKKIEEYTKKIEELIK
>15395:1:C-apoE (250–269), hEP-5
CIRLQAEAFQARLKSWFEPLV
>6100:1:
TTWEAWDRAIAEYAARIEALIRALQEQQEKNEAILREL
>3752:1:Mucroporin
LFGLIPSLIGGLVSAFK
>15680:1:RSV Fgp (497-515)[N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSLXFIXKSDXLLHNV
>15403:1:CP5-46-A-4D5E - Penetratin
GELDELVYLLDGPGYDPIHSRQIKIWFQNRRMKWKK
>15546:1:T20 [H6R, L8I, Q13R, E22K, L26V]
YTSLIRSIIEESRNQQEKNEQKLLEVDKWASLWNWF
>6679:1:
HCKFWA
>4644:1:NS5A-derived peptide C5A [I10K]
SWLRDIWDWKCEVLSDFK
>5956:1:Vif (51-59)
ISSEVHIPL
>6507:1:X- C41
XEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW
>16444:1:Pom-1
KCAGSIAWAIGSGLFGGAKLIKIKKYIAELGGLQ
>15638:1:
FKPSSPPSITLW
>15268:1:Surfactin-like peptide SLP4
EVll
>15792:1:Scrambled Claudin-1 (1-18)
AGALMFAWLLLGLQGIFN
>15287:1:SARS-CoV-S (259-278)
VLYNSTFFSTFKCYGVSATK
>10085:1:Dermaseptin-S1 (1-29)
ALWKTMLKKLGTMALHAGKAALGAAADTI
>6442:1:ACT- C34 -AMD
WMEWDREINNYTSLIHSLIEESQNQQEKNEQELL
>6012:1:
AEAASQVTN
>832:1:Maximin-1
GIGTKILGGVKTALKGALKELASTYAN
>15454:1:CP24
MTWEEWDKKIEEYTKKIEELIKKS
>6291:1:Reverse D IN (97-108)
wrGalkllfyat
>5901:1:EBR28 [I5A]
YQLLARMIYKNI
>15511:1:DENV-2 gp (412-444), DN59
MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY
>15784:1:Claudin-1 (23-40)
VSTALPQWRIYSYAGDNI
>7750:1:
HRALMRIRQMMT
>7300:1:
YRWWRWARRWYRWWRWARRW
>6511:1:C41 [S11X]
EWDREINNYTXLIHSLIEESQNQQEKNEQELLELDKWASLW
>13345:1:D5D
AVKRVGRRLKKLARKIARLGVAF
>10093:1:Dermaseptin-S1 (1-13)
ALWKTMLKKLGTM
>15291:1:SARS-CoV-S (690-709)
SNNTIAIPTNFSISITTEVM
>15442:1:GBV-A10 [P16L]
CWVRLGRYLLRRLKTLFT
>15507:1:DN80wt
MVDRGWGNHAGLFGKGSIV
>5444:1:Peptide Ctry2459 [K6H][N7H]
FLGFLHHLF
>15157:1:EK1C3
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSG
>5917:1:LCD278B
QLLIRMI
>6638:1:Enfuvirtide [S138N], T-20 [S138N]
YTSLIHSLIEENQNQQEKNEQELLELDKWASLWNWF
>6268:1:
TAYFLL
>15854:1:HTLV-1 gp (400-429)
CCFLNITNSHVSILQERPPLENRVLTGWGL
>6116:1:LEDGF (361-370)[K364A]
WNSLAIDNLDV
>15679:1:RSV Fgp (497-515)[A8,K12,E15,N19 - S-ALA-4-pen]
EKINQSLXFIRXSDXLLHXV
>15383:1:WQ-LDI
WEEWDKKIEEYTKKIEELIKKSQNQQLDI
>15229:1:MERS-S (1260-1280) [Y5,S9Ala-4-pen]
LDLTXEMLXLQQVVKALNESY
>15696:1:RSV Fgp (497-515)[D14A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSLXFIXKSAXLLHNV
>609:1:Dermaseptin S4 [M4D][N20D]
ALWDTLLKKVLKAAAKAALDAVLVGANA
>16540:1:NYAD-1
ITFXDLLXYYGP
>6053:1:HIV-1 integrase (95-107)
QETAYFLLKLAGR
>15415:1:GBV-A3
LLDCWVRLGRYLLRRLKTPFT
>6680:1:
HCKAWW
>15803:1:SARS-CoV Sgp (471-503)
ALNCYWPLNDYGFYTTTGIGYQPYRVVVLSFEL
>15550:1:T20 [H6W; S7K; L8,24V; I9L; E10N; E11D; S12A; Q13R; N14E; K18N; E20Q; Q21E; L26I]
YTSLIWKVLNDAREQQENNQETLVEIDKWASLWNWF
>15747:1:P-51
LEANIEELLKKAEEQQKKNEEELKKLEK
>15317:1:ACE2 (15-23)
NHEAEDLFY
>6182:1:
LQQLLFIAFRIGRRRRRRRR
>1647:1:Cicadin
NEYHGFVDKANNENKRKKQQGRDDFVVKPNNFANRRRKDDYNENYYDDVDAADVV
>6478:1:SC34EK
WXEWDRKIEEYTKKIEELIKKSQEQQEKNEKELK
>6028:1:Vpr (53-67)
TWAGVEAIIRILQQL
>15252:1:
KKKKVVLPFLFFF
>6244:1:IN (97-108)[G10A]
TAYFLLKLAARW
>5891:1:I33
QLLIRMIYKNILFYLVPGPGHGAEPERRNIKYL
>15481:1:MTSC33EK
MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEKEL
>15194:1:
IEEIKKKIEEIKKKIEEIKKKIEEIKKKIEEIKKKXK
>6301:1:Vpr-2 R8
IHFRIGRRRRRRRR
>6585:1:
RRKKRRRRRR
>15340:1:HCV (1975-1992)[R4W;D5E;I6,10V;C11L,E12H]
SWLWEVWDWVLHVLSDFK
>15710:1:FIV Egp (732-766)
LGEWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQ
>15205:1:MHV (1096–1117)[Y1117W]
GNHILSLVQNAPYGLYFIHFSW
>15655:1: 
>15655:2: 
>15655:3: 
>2250:1:D70, Uperin 7.1 [S11K][A12R][V13F]
GWFDVVKHIAKRF
>6643:1:Enfuvirtide [S138R], T-20 [S138R]
YTSLIHSLIEERQNQQEKNEQELLELDKWASLWNWF
>6213:1:IN (77-83)
VHVASGY
>5983:1:Apelin-12
RPRLSHKGPMPF
>15439:1:GBV-A10 [G6V]
CWVRLVRYLLRRLKTPFT
>15706:1:FIV Egp (728-760)
GNITLGEWYNQTKDLQQKFYEIIMDIEQNNVQG
>12169:1:Cycloviolacin Y5
GIPCAESCVWIPCTVTALVGCSCSDKVCYN
>15356:1:MERS-CoV-HR2P-Chol
SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL
>6069:1:Maximin H5r3
ILGPVLGLVSRTLRRVLGIL
>15643:1:SARS-CoV Sgp (553–572)[F558I]
RDVSDITDSVRDPKTSEILD
>15213:1:MERS-S (1252-1286)
LTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL
>15993:1:SAH-gp41 A,B
XTWXEWDXEINNYTSLIHSLIEESQNQXEKNXQELLE
>12755:1:DENV Envelope glycoprotein (340 – 354)
GQGKAHNGRLITANP
>5995:1:HIV-1 RT (506-525)
IQAQPDQSESELVNQIIEQL
>6340:1:
ETWETWWTEYWQATWIPEWE
>15301:1: 
>15301:2: 
>15301:3: 
>18533:1:Penilumamide D
XAX
>15751:1:P-63
QKIEELLKKAEEQQKKNEEELKKLEK
>15244:1:
AKDLEVVTSTYVLVEA
>15614:1:LP-80
WEQKIEELLKKAEEQQKKNEEELKKLEX
>15497:1:WQ-IDL
WEEWDKKIEEYTKKIEELIKKSQNQQIDL
>6602:1:P21, GBV-C E2 (61-78)
AIGWGDPITHWSHGQNRW
>6252:1:IN (129-139)[W3A]
ACAWAGIKQEF
>6317:1:Cathelicidin-4 / Indolicidin [K5G]
ILPWGWPWWPWRR
>15478:1:SC19EK
WEEWDKKIEEYTKKIEELI
>15182:1:HKU4-HR2P2 (1252-1287)
EISKINTTLLDLSDEMAMLQEVVKQLNDSYIDLKEL
>6225:1:IN (235-244)
WKGPAKLLWK
>6675:1:
HCKFWI
>15663:1:P-52
WEQKIEELLKKAEEQQKKNEEELKKLEK
>15399:1:apoE (135–162), hEP-9
VRLASHLRKLRKRLLRDADDLQKRLAVY
>15233:1:MERS-S (1260-1280) [A16,S20Ala-4-pen]
LDLTYEMLSLQQVVKXLNEXY
>15726:1:LP-60
SLIEELIKKSEEQQKKNEEELKKLEX
>15376:1:MT-WQ
MTWEEWDKKIEEYTKKIEELIKKSQNQQ
>613:1:Dermaseptin S4 (1-16)
ALWMTLLKKVLKAAAK
>6049:1:HIV-1 integrase (95-109)
QETAYFLLKLAGRWP
>15458:1:FCoV Sgp (1338-1359)
FNATYLNLTGEIDDLEFRSEKL
>6272:1:
ACWWAG
>15264:1:SR9EK1
IEEINKKVEEIQKKIEELNKKAEELNKKLEELQKK
>15321:1:NS5A-derived peptide D-C5A
swlrdiwdwicevlsdfk
>10089:1:Dermaseptin-S1 (1-15)[W31NAL]
ALXKTMLKKLGTMAL
>15858:1:DENV2 Ep (419-447)
AWDFGSLGGVFTSIGKALHQVFGAIYGAA
>6264:1:IN (129-139)[C2S]
ASWWAGIKQEF
>6634:1:Enfuvirtide [S138F], T-20 [S138F]
YTSLIHSLIEEFQNQQEKNEQELLELDKWASLWNWF
>15272:1:Surfactin-like peptide SLP8
EVllD
>15788:1:Claudin-1 (1-20)
MANAGLQLLGFILAFLGWIG
>18505:1:Euryjanicin A
WPISFVP
>15337:1:HCV (1975-1992)[I6D,E12T,S15T]
SWLRDVWDWICTVLTDFK
>6458:1:
EEYTKKIEEYTKKIEEYTKKIEEYTKKIWASLWNWF
>15419:1:GBV-A7
CWVRLGRYLLRRLKTPFTRL
>6399:1:
YGGIKKEIEAIKKEQEAIKKKIEAIEKEIEA
>6233:1:IN (97-108)[L5A]
TAYFALKLAGRW
>15225:1:MERS-S (1260-1280) [Q12,A16Ala-4-pen]
LDLTYEMLSLQXVVKXLNESY
>15360:1:HCV gp (713-725)
AIKWEYVLLLFLL
>15730:1:LP-64
KIEELLKKAEEQQKKNEEELKKLEX
>15527:1:JEV Ep (424–452)
AWDFGSIGGVFNSIGRAVHQVFGGAFRTL
>6618:1:Rev (34-50) -A4C-RTD
TRQARRNRRRRWRERQRAAAACYGRKKRRQRRR
>6248:1:IN (97-108)[W12A]
TAYFLLKLAGRA
>1098:1:Dermaseptin-3, DS III, Dermaseptin-S3, DS3
ALWKNMLKGIGKLAGKAALGAVKKLVGAES
>4330:1:Peptide Hp1036
ILGKIWEGIKSIF
>107:1:Dermaseptin S4 (1-16)AMD[M4K]
ALWKTLLKKVLKAAAK
>15462:1:FCoV Sgp (1338-1387)
FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNLEWLNRIE
>15198:1:SARS-CoV CP1, SARS-CoV (1153-1189)
GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE
>16537:1:7R-Ahx-P3
RRRRRRRXGSLLGRMKGA
>6024:1:
AEAMSQVANTATIM
>6474:1:SC22EK
WEEWDKKIEEYTKKIEELIKKS
>2572:1:Caerin 1.9
GLFGVLGSIAKHVLPHVVPVIAEKL
>5960:1:Vif (81-88)
LGQGVSIE
>15435:1:GBV-A10 [L9S]
CWVRLGRYSLRRLKTPFT
>150:1:LL-37 (13-32)[I13G,G14I]
GIKEFKRIVQRIKDFLRNLV
>13332:1:DC1
FAVAVKAVAVKAVAVKAVKKAVKKVKKAVKKAVKKKK
>6073:1:GLK-19
GLKKLLGKLLKKLGKLLLK
>6566:1:
RQLLSGIDQEQNNLTRLIEAQIHELQK
>15659:1:SARS-CoV-2 HR1P
ANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQ
>15209:1:SARS-CoV (902-947)
QKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQ
>15566:1:
kkWk
>6659:1:CCR5 ECL2 (178-191)
CSSHFPYSQYQFWK
>146:1:LL-37 fragment KR-12
KRIVQRIKDFLR
>5999:1:HIV-1 RT (519-532)
NQIIEQLIKKEKVY
>15423:1:GBV-A11
WVRLGRYLLRRLKTPFTR
>6065:1:Ranatuerin-3 (1-13)[N7E,L9I,G10A,T12S,F13W]
GFLDIIEKIAKSW
>16960:1:AHB1
DEDLEELERLYRKAEEVAKEAKDASRRGDDERAKEQMERAMRLFDQVFELAQELQEKQTDGNRQKATHLDKAVKEAADELYQRVR
>6120:1:LEDGF (361-370)[L368A]
WNSLKIDNADV
>6570:1:ACT- N36
SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
>15862:1:DENV2 Ep (419-447)[A24G,I25A,Y26F]
AWDFGSLGGVFTSIGKALHQVFGGAFGAA
>4633:1:NS5A-derived peptide C5A [I10L]
SWLRDIWDWLCEVLSDFK
>5921:1:Vif (9-16)
IVWQVDRM
>15161:1:EK1C7
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG
>15531:1:Alloferon (4-13)
SGHGQHGVHG
>15474:1:SC23EK
WEEWDKKIEEYTKKIEELIKKSE
>12132:1:Alloferon-1 [H1K]
KGVSGHGQHGVHG
>6032:1:Vpr (69-83)
FIHFRIGCQHSRIGI
>1718:1:Parasin I
KGRGKQGGKVRAKAKTRSS
>6177:1:
LQALLFIHFRIGRRRRRRRR
>15618:1:LP-94
IEELLKKAEEQQKKNEEELKKLEK
>15248:1:
ADLEVVAATFVLVA
>12133:1:Alloferon-1 [H1R]
RGVSGHGQHGVHG
>6033:1:
KGEAMHGQVDCSPGIWQLDC
>6176:1:
LAQLLFIHFRIGRRRRRRRR
>15619:1:LP-95
IEELLKKAEEQQKKNEEELKK
>15249:1:
ADLEVVAATYVLVA
>15863:1:WNV gp (419-447)
AWDFGSVGGVFTSVGKAVHQVFGGAFRSL
>4632:1:NS5A-derived peptide C5A [I6L]
SWLRDLWDWICEVLSDFK
>5920:1:Vif (1-8)
MENRWQVM
>15160:1:EK1C6
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG
>15530:1:Alloferon (3-13)
VSGHGQHGVHG
>15475:1:SC22EK
WEEWDKKIEEYTKKIEELIKKS
>6064:1:
MTWMAWDRAIANYAALIHALIEAAQNQQEKNEAALLEL
>6434:1:
PFVFLR
>12164:1:Cycloviolacin O14
GSIPACGESCFKGKCYTPGCSCSKYPLCAKN
>16961:1:AHB2
ELEEQVMHVLDQVSELAHELLHKLTGEELERAAYFNWWATEMMLELIKSDDEREIREIEEEARRILEHLEELARK
>6121:1:LEDGF (361-370)[D369A]
WNSLKIDNLAV
>6571:1:C8- N36
SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
>15567:1:
kkwk
>147:1:LL-37 (16-32)[E1G], LL-37 fragment GF-17
GFKRIVQRIKDFLRNLV
>15422:1:GBV-A10
CWVRLGRYLLRRLKTPFT
>13333:1:D1D6
FLAAARIAKRVAKKARKLAKRAARKRK
>6072:1:Dermaseptin-S9r3
GLRSRIWLWVLLMIWQESNRFKRM
>15658:1: 
>15658:2: 
>15658:3: 
>15208:1:SARS-CoV (1153–1175)
GINASVVNIQKEIDRLNEVAKNL
>15822:1:HCV gp (1155-1169), NS3proC-C15
PRPISYLKGSSGGPL
>4223:1:Caerin-1.2
GLLGVLGSVAKHVLPHVVPVIAEHL
>5961:1:Vif (85-92)
VSIEWRKK
>15434:1:GBV-A10 [L9K]
CWVRLGRYKLRRLKTPFT
>151:1:LL-37 (13-32)[I13G,G14I,F17Phg]
GIKEXKRIVQRIKDFLRNLV
>16536:1:7R-Ahx-HBV Large envelope protein (219-243)
RRRRRRRXPTSNHSPTSCPPTCPGYRWMCLRRF
>6475:1:C29
WMEWDREINNYTSLIHSLIEESQNQQEKN
>15526:1:JEV Ep (418–452)
AALGDTAWDFGSIGGVFNSIGRAVHQVFGGAFRTL
>6619:1:Rex (1-21)
MPKTRRRPRRSQRKRPPTPWP
>4331:1:Peptide Hp1239
ILSYLWNGIKSIF
>15463:1:SC34EK
WEEWDKKIEEYTKKIEELIKKSEEQQKKNEKELK
>15199:1:SARS-CoV (770-788)[Y771W]
MWKTPTLKYFGGFNFSQIL
>15224:1:MERS-S (1260-1280) [Q11,K15Ala-4-pen]
LDLTYEMLSLXQVVXALNESY
>15361:1:D-HCV gp (713-725)
aikweyvlllfll
>18553:1:D-Cathelicidin-4 / Indolicidin [R12P][R13P] Dimer 
>18553:2:D-Cathelicidin-4 / Indolicidin [R12P][R13P] Dimer 
>15731:1:LP-65
IEELLKKAEEQQKKNEEELKKLEX
>15418:1:GBV-A6
LDCWVRLGRYLLRRLKTPFTRL
>13173:1:Human Defensin-5 (1-9)
ATCYCRTGR
>6398:1:
IKKEIEAIKKEQEAIKKKIEAIEKLLQLTVWGIKQLQARIL
>6662:1:CCR5 ECL2 (172-187)
EGLHYTCSSHFPYSQY
>6232:1:IN (97-108)[F4A]
TAYALLKLAGRW
>15273:1:Surfactin-like peptide SLP9
EDVll
>15789:1:Claudin-1 (1-22)
MANAGLQLLGFILAFLGWIGAI
>18504:1:Euryjanicin D
FPXFSPX
>15336:1:HCV (1975-1992) scrambled
SIWRDWVDLICEFLSDWK
>6459:1:
WMEWDREIEEYTKKIEEYTKKIEEYTKKIWASLWNWF
>6265:1:IN (129-139)[W3G]
ACGWAGIKQEF
>15859:1:DENV3 Ep (419-447)
AWDFGSVGGVLNSLGKMVHQIFGSAYTAL
>6635:1:Enfuvirtide [S138Y], T-20 [S138Y]
YTSLIHSLIEEYQNQQEKNEQELLELDKWASLWNWF
>15265:1:Surfactin-like peptide SLP1
EVlADlV
>15320:1:ACE2 (4-26)-G-ACE2 (333-339)
EEQAKTFLDKFNHEAEDLFYQSSGLGKGDFR
>10088:1:Dermaseptin-S1 (1-19)
ALWKTMLKKLGTMALHAGK
>15459:1:FCoV Sgp (1338-1366)
FNATYLNLTGEIDDLEFRSEKLHNTTVEL
>757:1:Circulin-B, CIRB
GVIPCGESCVFIPCISTLLGCSCKNKVCYRN
>15662:1:Alstotide S1
CRPYGYRCDGVINQCCDPYHCTPPLIGICL
>15398:1:apoE (131–155), hEP-8
EELRVRLASHLRKLRKRLLRDADDL
>15232:1:MERS-S (1260-1280) [K15,E19Ala-4-pen]
LDLTYEMLSLQQVVXALNXSY
>15727:1:LP-61
IEELIKKSEEQQKKNEEELKKLEX
>15377:1:WQ-SM
WEEWDKKIEEYTKKIEELIKKSQNQQSM
>6048:1:HIV-1 integrase (82-89)
GYIEAEVI
>491:1:Cathelicidin-4, Indolicidin
ILPWKWPWWPWRR
>6224:1:IN (193-202)
GYSAGERIVD
>6674:1:
HCKFWW
>5185:1:D Kalata-B1 
GlpvcGetcvGGtcntpGctcswpvctrn
>15496:1:MTSC18EK
MTWEEWDKKIEEYTKKIEEL
>6603:1:P23, GBV-C E2 (67-84)
PITHWSHGQNRWPLSCPQ
>6253:1:IN (129-139)[W4A]
ACWAAGIKQEF
>6316:1:Cathelicidin-4 / Indolicidin [K5G][R12P][R13P]
ILPWGWPWWPWPP
>15479:1:SC18EK
WEEWDKKIEEYTKKIEEL
>15183:1:HKU4-HR2P3 (1261-1296)
LDLSDEMAMLQEVVKQLNDSYIDLKELGNYTYYNKW
>1650:1:Gymnin
KTCENLADDY
>15300:1: 
>15300:2: 
>18532:1:Penilumamide C
XXX
>15750:1:P-62
EQKIEELLKKAEEQQKKNEEELKKLEK
>15245:1:
KKKKVAAATYVLV
>15615:1:LP-83
WEQKIEELLKKAEEQQKKNEEELKKLEKC
>15992:1:SAH-gp41 B
XTWMEWDREINNYTSLIHSLIEESQNQXEKNXQELLE
>12754:1:DENV Envelope glycoprotein (98-109)
DRGWGNGCGLFG
>5994:1:HIV-1 RT (516-535)
ELVNQIIEQLIKKEKVYLAW
>6341:1:
LQDSGLEVNIVTDSQYALGI
>6711:1:P5
NVTLLCDCPNGPWVWVPAFC
>15707:1:FIV Egp (729-761)
NITLGEWYNQTKDLQQKFYEIIMDIEQNNVQGK
>12168:1:Cycloviolacin Y4
GVPCGESCVFIPCITGVIGCSCSSNVCYLN
>15357:1:MERS-CoV-HR2P-C16
SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL
>6068:1:Cecropin-1 (1-13)[G7E,K8S,K9I,E11D,R12A,V13F]
GWLKKIESIIDAF
>12187:1:Cycloviolacin Y1
GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN
>15642:1:SARS-CoV Sgp (470–489)[N479K]
PALNCYWPLKDYGFYTTSGI
>15212:1:
KKKKYRNIRRPG
>6642:1:Enfuvirtide [S138H], T-20 [S138H]
YTSLIHSLIEEHQNQQEKNEQELLELDKWASLWNWF
>6212:1:IN (51-67)
HGQVDCSPGIWQLDCTH
>6357:1:
WQCLTLTHRGFVLLTITVLR
>5982:1:Apelin-13
QRPRLSHKGPMPF
>15438:1:GBV-A10 [G6A]
CWVRLARYLLRRLKTPFT
>6584:1:
GRKKRRRRRR
>15341:1:HCV (1975-1992)[S1T,D5A,I10V,E12T,V13A,S15T]
TWLRAIWDWVCTALTDFK
>15711:1:FIV Egp (733-767)
GEWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQL
>15204:1:AAC-SARS-CoV (1170–1194)
AACEVAKNLNESLIDLQELGKYEQYIKW
>15654:1: 
>15654:2: 
>6245:1:IN (97-108)[R11A]
TAYFLLKLAGAW
>15480:1:MTSC34EK
MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEKELK
>15195:1:
IEEIEKKIEEIEKKIEEIEKKIEEIEKKIEEIEKKXK
>6300:1:Vpr-1 R8
LQQLLFRRRRRRRR
>15746:1:P-50
YTSLIEELIKKSEEQQKKNEEELKKLEK
>12129:1:Alloferon-1
HGVSGHGQHGVHG
>15316:1:ACE2 (12-20)
DKFNHEAED
>6183:1:
LQQLLFIHARIGRRRRRRRR
>6029:1:Vpr (57-71)
VEAIIRILQQLLFIH
>15603:1:
EMTWEEWEKKIEEYTKKIEEILKKSQNQQIDL
>15253:1:
KKKKFVAATYVLV
>872:1:Buforin-2, Histone H2A
TRSSRAGLQFPVGRVHRLLRK
>15414:1:GBV-A2
LLDCWVRLGRYLLRRLKTPFTRL
>6681:1:
ACKFWW
>15802:1:Griffithsin
SLTHRKFGGSGGSPFSGLSSIAVRSGSYLDAIIIDGVHHGGSGGNLSPTFTFGSGEYISNMTIRSGDYIDNISFETNMGRRFGPYGGSGGSANTLSNVKVIQINGSAGDYLDSLDIYYEQY
>6394:1:
RMKQIEDKIEEIESKQKKIENEIARIKKLIEAQQHLLQLTVWGIKQLQARIL
>15551:1:T20 [H6R; S7E; L8,26I; I9M; E10N; E11K; Q13W; N14G; E17R; K18R; Q21G; E22T; L24A]
YTSLIREIMNKSWGQQRRNEGTLAEIDKWASLWNWF
>6117:1:LEDGF (361-370)[I365A]
WNSLKADNLDV
>15678:1:RSV Fgp (497-515)
EKINQSLAFIRKSDELLHNV
>15382:1:WQ-IDI
WEEWDKKIEEYTKKIEELIKKSQNQQIDI
>15228:1:MERS-S (1260-1280) [D2,E6Ala-4-pen]
LXLTYXMLSLQQVVKALNESY
>15697:1:RSV Fgp (497-515)[L16A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSLXFIXKSDXALHNV
>6402:1:
IKKEIEAIKKEQEAIKKKIEAIEKEISGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
>6052:1:HIV-1 integrase (196-210)
AGERIVDIIATDIQ
>15443:1:GBV-A10 [L9I]
CWVRLGRYILRRLKTPFT
>825:1:Theta defensin 3, RTD-3  
GFCRCICTRGFCRCICTR
>15506:1:DN57opt
RWMVWRHWFHRLRLPYNPGKNKQNQQWP
>15156:1:EK1C2
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSG
>5445:1:Peptide Ctry2459 [G3H][K6H][N7H]
FLHFLHHLF
>5916:1:LCE40
YQLLIRMI
>6639:1:Enfuvirtide [S138Q], T-20 [S138Q]
YTSLIHSLIEEQQNQQEKNEQELLELDKWASLWNWF
>15855:1:BLV gp (391-419)
CCFLRIQNDSIIRLGDLQPLSQRVSTDWQ
>6269:1:
YFLLKL
>15785:1:Claudin-1 (26-43)
ALPQWRIYSYAGDNIVTA
>7751:1:
HRIAMRIRQMMT
>6510:1:C41 [S11X]
EWDREINNYTXLIHSLIEESQNQQEKNEQELLELDKWASLW
>13344:1:D4B
FKVKAKVKAKVKAKVKAKKKK
>10092:1:Dermaseptin-S1 (1-14)
ALWKTMLKKLGTMA
>15290:1:SARS-CoV-S (598-617)
YQDVNCTDVSTAIHADQLTP
>15455:1:CP24-IBP
MTWEEWDKKIEEYTKKIEELIKKSDCAWHLGELVWCT
>6290:1:Reverse IN (97-108)
WRGALKLLFYAT
>6785:1:Neutrophil defensin 3, HNP-3
DCYCRIPACIAGERRYGTCIYQGRLWAFCC
>5900:1:EBR28 [L4A]
YQLAIRMIYKNI
>15510:1:1OAN1
FWFTLIKTQAKQPARYRRFC
>6506:1:X- C41
XEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW
>6156:1:
AIIRILQQLLFIHFRIGRRRRRRRR
>3354:1:Peptide Hp1035
IFSAIGGFLKSIF
>15639:1:SARS-CoV Sgp (220-239)[N227K,S239L]
FKLPLGIKITNFRAILTAFL
>15269:1:Surfactin-like peptide SLP5
EVlDl
>15793:1:Claudin-1 (53-80)
SCVSQSTGQIQCKVFDSLLNLSSTLQAT
>15286:1:SARS-CoV-S (259-278)
PTTFMLKYDENGTITDAVDC
>6013:1:
AEAMAQVTN
>15402:1:C-apoE (141–150)-C, hEP-12
CLRKLRKRLLRC
>15547:1:T20 [I5L, H6R, Q13R, Q15L, E22A, L26V]
YTSLLRSLIEESRNLQEKNEQALLEVDKWASLWNWF
>6678:1:
HCKFAW
>5957:1:Vif (55-62)
VHIPLGDA
>15394:1:C-apoE (135–155), hEP-4
CVRLASHLRKLRKRLLRDADDL
>6101:1:
TTWEAWDRAIAEYAARIEALIRAAQEQQEKLEAALREL
>3753:1:Mucroporin-M1, Mucroporin [G3,11R,P6K,G10K]
LFRLIKSLIKRLVSAFK
>18549:1:Cathelicidin-4 / Indolicidin [R12P][R13P] Dimer 
>18549:2:Cathelicidin-4 / Indolicidin [R12P][R13P] Dimer 
>15681:1:RSV Fgp (497-515)[K2R-ALA-4-pen; Q5,A8,K12 -S-ALA-4-pen]
EXINXSLXFIRXSDELLHNV
>15409:1:GBV-B gp (1872-1889)
IWQYVCNFFVICFNVLKA
>6223:1:IN (181-188)
FIHNFKRK
>6389:1:
RMKQIEDKIEEIESKQKKIENEIARIKKLLQLTVWGIKQLQARIL
>15665:1:LP-78
WEQKIEELLKKAEEQQKKNEEELKKLEX
>17208:1:ACE2 (27-41)
TFLDKFNHEAEDLFYQ
>15235:1:MERS-S (1260-1280) [M7Nle; Q12,A16Ala-4-pen]
LDLTYEXLSLQXVVKXLNESY
>15720:1:LP-54
YTSLIEELIKKSEEQQKKNEEELKX
>15370:1:HCV gp (710-721)
VSFAIKWEYVLL
>2372:1:Pseudin-1
GLNTLKKVFQGLHEAIKLINNHVQ
>6624:1:RhoA 77-95
TDVILMCFSIDSPDSLENI
>6274:1:
WAGIKQ
>15262:1:SARS-CoV-S (1151-1185), SR9, SARS-CoV-2-S (1169-1203), IPB01
ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL
>15327:1:HCV (1974-1992)
GSWLRDIWDWICEVLSDFK
>15777:1:Claudin-1 (1-18)
MANAGLQLLGFILAFLGW
>13709:1:Human Defensin-5, HD5 [T7R]
ATCYCRRGRCATRESLSGVCEISGRLYRLCCR
>6018:1:
AEAM
>6448:1:
WMEWDRKIEEYTKKIEELIKKSQEQQEKNEKELK
>15448:1:GBV-A10 [C1E,Y8E,T15E,T18E]
EWVRLGRELLRRLKEPFE
>2364:1:Clavanin-B
VFQFLGRIIHHVGNFVHGFSHVF
>6262:1:IN (97-108)[K7I]
TAYFLLILAGRW
>6632:1:Enfuvirtide [S138P], T-20 [S138P]
YTSLIHSLIEEPQNQQEKNEQELLELDKWASLWNWF
>15274:1:Surfactin-like peptide SLP10
EVlDl
>4199:1:Tilapia piscidin 4, TP4
FIHHIIGGLFSAGKAIHRLIRRRRR
>1231:1:Misgurin
RQRVEELSKFSKKGAAARRRK
>15331:1:HCV (1975-1994)[L3R,R4L,V13S,L14V,S15L]
SWRLDIWDWICESVLDFK
>18503:1:Euryjanicin C
LFPXSXP
>2299:1:D94, Bacteriocin plantaricin J, Bacteriocin PlnJ
GAWKNFWSSLRKGFYDGEAGRAIRR
>6720:1:
WDRGNVTLLSDSPNGPWVWV
>13174:1:Human Defensin-5 (1-13)
ATCYCRTGRCATR
>1773:1:Leaf cyclotide, Vhl-1
CGESCAXISFCFTEVIGCSCKNKVCYLNSIS
>15223:1:MERS-S (1260-1280) [S9,V13Ala-4-pen]
LDLTYEMLXLQQXVKALNESY
>15673:1:LP-92
IEELLKKAEEQQKKNEEELKX
>15389:1:apoE (131-162)+(244+272), hEP
EELRVRLASHLRKLRKRLLRDADDLQKRLAVYEEQAQQIRLQAEAFQARLKSWFEPLVEDM
>15366:1:HCV gp (716-725)
WEYVLLLFLL
>15736:1:LP-71
IEEYTKKIEEILKKSEEQQKKNEEELKKLEX
>6059:1:Uperin-2.7 (1-13)[V10F,G11E,G12S,I13W]
GIIDIAKKLFESW
>6409:1:
KIKKIENEIARIKKLLQLTVWGIKQLQARIL
>15521:1:Human albumin (597-609), K13L
KKLVAASQAALGL
>15171:1:HCoV-OC43-HR1P
ANAFNNALDAIQEGFDATNSALVKIQAVVNADAEALNNLLQQ
>15464:1:SC33EK
WEEWDKKIEEYTKKIEELIKKSEEQQKKNEKEL
>6022:1:
AEAASQVTNTATIM
>6537:1:C8- N27
RQLLSGIVQQQNNLLRAIEAQQHLLQK
>15258:1:PEDV-S HR2P, PCov-S HR2P
PLDVFNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWLNRVET
>4224:1:Caerin-1.7
GLFKVLGSVAKHLLPHVAPVIAEKL
>6219:1:IN (129-139)
ACWWAGIKQEF
>5966:1:VMI 9
LPLPAPSFHRTT
>156:1:Cathelicidin-6 (1-18)[K9P,L17I]
GRFKRFRKPFKKLFKKIS
>506:1:Temporin-A
FLPLIGRVLSGIL
>10261:1:R7
RRRRRRR
>15599:1:HNP-4 (1-11)
VCSCRLVFCRR
>6425:1:
PFVFLM
>13334:1:D4C3
FRFKIKFRLKFRFKARFKFRAKFRA
>16970:1:SARS-CoV-2-S (1183-1205), IPB06
IDRLNEVAKNLNESLIDLQELGK
>6560:1:Envelope glycoprotein gp160 (555-576), C16- N22 
SGIVQQQNNLLRAIEAQQHLLQ
>15560:1:Eval418-FH3
LWHHIWNFVHGLI
>15425:1:T21N17
RIQQIEQKIHHIEQRIQQIEQLLQLTVWGIKQLQARIL
>17048:1:EK1-GSGSGC
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSGC
>843:1:Maximin 5
SIGAKILGGVKTFFKGALKELASTYLQ
>1525:1:Nigrosin-OG21 antimicrobial peptide
GLLSGVLGVGKKVLCGLSGLC
>140:1:LL-37 [F5,6L]
LLGDLLRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
>12163:1:Cycloviolacin O13
GIPCGESCVWIPCISAAIGCSCKSKVCYRN
>6599:1:P11, GBV-C E2 (31-48)
TGEKVWDRGNVTLLCDCP
>6063:1:Ponericin-W3 (1-13)[G4S,T5D,K8E,G10I,I11K,A13F]
GIWSDLAEIIKKF
>6433:1:
PEVFLM
>6126:1:LEDGF (365-369)
WIDNLD
>6576:1:
SGIVQQLNNQLRAEEANQHLEQLSVWGSKQNQARRLK
>15219:1:MERS-S (1260-1280) [D2,E6Ala-4-pen]
LXLTYXMLSLQQVVKALNESY
>16966:1:SARS-CoV-2-S (1169-1203)-K, IPB02
ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELK
>15649:1: 
>15649:2: 
>15167:1:MERS-CoV-HR1P
ANKFNQALGAMQTGFTTTNEAFRKVQDAVNNNAQALSKLASE
>15537:1:Alloferon (10-13)
GVHG
>15864:1:WNV gp (419-447)[G24W,A25W,F26W]
AWDFGSVGGVFTSVGKAVHQVFGWWWRSL
>6258:1:IN (129-139)[Q9A]
ACWWAGIKAEF
>6608:1:P59, GBV-C E2 (175-192)
RFPFHRCGAGPKLTKDLE
>4635:1:NS5A-derived peptide C5A [I6L,I10L]
SWLRDLWDWLCEVLSDFK
>5927:1:Vif (51-65)
ISSEVHIPLGDARLV
>15472:1:SC25EK
WEEWDKKIEEYTKKIEELIKKSEEQ
>15188:1:
LEELSKKLEELSKKLEELSKKLEELSKKLEELSKKXK
>6034:1:
ASCDKCQLKGEAMHG
>12134:1:Alloferon-1 [H1A]
AGVSGHGQHGVHG
>7760:1:
HRILMRIR
>6171:1:
EAIERILKQLLFIHFRIGRRRRRRRR
>6106:1:
TTWEAWDRAIAEYAARIEALIRAAQELQEKLEAALRE
>1339:1:Spinigerin
HVDKKVADKVLLLKQLRIMRLLTRL
>6556:1:C16- N25
RQLLSGIVQQQNNLLRAIEAQQHLL
>15239:1:K-HCV (1677-1691)-K
KGSVVIVGRIILSGRK
>15669:1:LP-88
EQKIEELLKKAEEQQKKNEEELKKLEX
>15393:1:C-apoE (244–272), hEP-3
CEEQAQQIRLQAEAFQARLKSWFEPLVEDM
>15686:1:RSV Fgp (497-515)[E1A;N4,A8,R11,E15 - S-ALA-4-pen]
AKIXQSLXFIXKSDXLLHNV
>2450:1:T22, Polyphemusin II [Tyr-5,12, Lys-7]
RRWCYRKCYKGYCYRKCR
>16550:1:Deca-(ARG)10
wrrrrrrrrrrG
>18237:1:Human Cathelicidin, LL-37
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
>15405:1:WNV-GP1 (2998-3015)
AKGSRAIWFMWLGARFLE
>2283:1:Ponericin-L2
LLKELWTKIKGAGKAVLGKIKGLL
>4642:1:NS5A-derived peptide C5A [I10S]
SWLRDIWDWSCEVLSDFK
>15540:1:Alloferon (1-8)
HGVSGHGQ
>15794:1:Claudin-6 (1-18)
MASAGMQILGVVLTLLGW
>2542:1:Defensin MGD1(25-33) peptide D
CGGWKRKRC
>3353:1:Peptide Hp1090, Um5
IFKAIWSGIKSLF
>6151:1:
EAIIRILQQLLFIHFRIGRRRRRRRR
>6014:1:
AEAMSQVAN
>15281:1:SARS-Cov-S (899-958)
HHHHHHYENQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSV
>15452:1:HCV gp (692–706), E2-78
GLLHLHQNIVDVQYM
>15517:1:L12P
LCLRNWDQGHRP
>6628:1:Enfuvirtide [S138V], T-20 [S138V]
YTSLIHSLIEEVQNQQEKNEQELLELDKWASLWNWF
>5907:1:EBR28 [N11A]
YQLLIRMIYKAI
>6517:1:C41 [N22X]
EWDREINNYTSLIHSLIEESQXQQEKNEQELLELDKWASLW
>15278:1:Caerin 1.1 [S4K;H12,16,24K]
GLLKVLGSVAKKVLPKVVPVIAEKL
>7756:1:
HRILMRIRQAMT
>15782:1:Claudin-1 (17-34)
GWIGAIVSTALPQWRIYS
>15297:1: 
>15297:2: 
>2368:1:Mastoparan-VT1
INLKAIAALAKKLL
>15444:1:GBV-A10 [L9I,L13I]
CWVRLGRYILRRIKTPFT
>15852:1:2P23
EMTWEEWEKKVEELEKKIEELLK
>15501:1:Urumin
IPLRGAFINGRWDSQCHRFSNGAIACA
>15385:1:MT-WQ-IDL
MTWEEWDKKIEEYTKKIEELIKKSQNQQIDL
>6110:1:LEDGF (361-370)[S362A]
WNALKIDNLDV
>6405:1:
KIEEIESKQKKIENEIARIKKLLQLTVWGIKQLQARIL
>16546:1:Deca-(ARG)6
wrrrrrrG
>6055:1:Aurein-1.2 [F13W]
GLFDIIKKIAESW
>18558:1:Chrysogeamide A
AVXGVl
>15690:1:RSV Fgp (497-515)[S6A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQALXFIXKSDXLLHNV
>2295:1:D88, Distinctin chain 1 [C23R]
NLVSGLIEARKYLEQLHRKLKNRKV
>5100:1:Defensin-1-Ir, Def1-Ir
GGYYCPFFQDKCHRHCRSFGRKAGYCGGFLKKTCICV
>15413:1:GBV-A1
LLDCWVRLGRYLLRRLKT
>15556:1:Alloferon [H14-Cl-PHE]
XGVSGHGQHGVHG
>6239:1:IN (97-108)[K7A]
TAYFLLALAGRW
>6393:1:
RMKQIEDKIEEIESKQKKIENEIARIKKLLQLTVWDIKQLQARIL
>6184:1:
LQQLLFIHFAIGRRRRRRRR
>15741:1:LP-11
EMTWEEWEKKIEEYTKKIEEILXX
>15311:1:SARS-CoV-S (1134-1193)
ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK
>15604:1:
EMTWEEWEKKIEEYIKKIEEILKKSQNQQIDL
>6868:1:KP
AKVTMTCSAS
>15254:1:
ADLEVVAATYVLDD
>2981:1:Palicourein
GDPTFCGETCRVIPVCTYSAALGCTCDDRSDGLCKRN
>15487:1:MTSC27EK
MTWEEWDKKIEEYTKKIEELIKKSEEQQK
>5897:1:EBR28
YQLLIRMIYKNI
>6612:1:P124, GBV-C E2 (370-387) 
WVNQLAVLGLPAVDAAVA
>1568:1:Antifungal lectin PVAP
SNDIYFNFQR
>15468:1:SC29EK
WEEWDKKIEEYTKKIEELIKKSEEQQKKN
>1991:1:Caerin-1.20
GLFGILGSVAKHVLPHVIPVVAEHL
>15192:1:
IEEIHKKIEEIHKKIEEIHKKIEEIHKKIEEIHKKXK
>15346:1:HCV (1975-1992)[R4D,K18E]
SWLDDIWDWICEVLSDFE
>15716:1:FIV Egp (738-772)
QTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKWED
>6583:1:
RRKKRRQRRR
>13338:1:D2A3
KKKKFVKKVAKKVKKVAKKVAKVAVAV
>6429:1:
PFVYLI
>6096:1:
MTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAALREL
>15203:1:SARS-CoV (1169–1199)
NEVAKNLNESLIDLQELGKYEQYIKWPWYVW
>15653:1: 
>15653:2: 
>12196:1:Cycloviolin A
GVIPCGESCVFIPCISAAIGCSCKNKVCYRN
>6215:1:IN (97-108)
TAYFLLKLAGRW
>17117:1:CMK
RVKR
>15595:1:Pa-MAP 1.6, Antifreeze peptide analogue
KTAATLADTLADTAATLAKAAAA 
>6350:1:
LLEY
>15700:1:RSV Fgp (497-515)[V20A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSLXFIXKSDXLLHNA
>15350:1:HCV (1975-1992)[D5,8,16R;E12K]
SWLRRIWRWICKVLSRFK
>18562:1:Scopularide B
AFXGVl
>15645:1:SARS-CoV Sgp (690–709)[S701L]
SNNTIAIPTNFLISITTEVM
>2539:1:Defensin MGD1 (25-33) peptide B
CGGWHRLRC
>15215:1:Beta-defensin 4, MBD-4
IINNPITCMTNGAICWGPCPTAFRQIGNCGHFKVRCCKIR
>12753:1:DENV Envelope glycoprotein (25-41)
LEHGSCVTTMAKDKPTL
>6346:1:
LLEYSL
>5993:1:HIV-1 RT (176-195)
PDIVIYQYMDDLYVGSDLEI
>15429:1:(T21N17)3 
>15429:2:(T21N17)3 
>15429:3:(T21N17)3 
>14:1:Brevinin-2 related peptide B2RP   
GIWDTIKSMGKVFAGKILQNL
>15307:1:SARS-CoV (1126-1189)[F5P]
ELDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE
>15757:1:P-73
VEELEKKIEELLKKAEEQQKKNEEELKKLEK
>6038:1:
VDCSPGIWQLDCTHL
>15242:1:
ADLEVVAATYVDVA
>15612:1:LP-51
LEANIEELLKKAEEQQKKNEEELKKLEX
>4639:1:NS5A-derived peptide C5A [I10V]
SWLRDIWDWVCEVLSDFK
>6604:1:P25, GBV-C E2 (73-90)
HGQNRWPLSCPQYVYGSV
>6254:1:IN (129-139)[G6A]
ACWWAAIKQEF
>15491:1:MTSC23EK
MTWEEWDKKIEEYTKKIEELIKKSE
>15184:1:
AEEASKKAEEASKKAEEASKKAEEASKKAEEASKKXK
>6605:1:P45, GBV-C E2 (133-150)
SDRDTVVELSEWGVPCAT
>4638:1:NS5A-derived peptide C5A [I6L,I10L,V13L]
SWLRDLWDWLCELLSDFK
>6255:1:IN (129-139)[I7A]
ACWWAGAKQEF
>15490:1:MTSC24EK
MTWEEWDKKIEEYTKKIEELIKKSEE
>15185:1:
VEEVSKKVEEVSKKVEEVSKKVEEVSKKVEEVSKKXK
>18534:1:Asperpeptide A
AAPXY
>15306:1:SARS-CoV-S (1161–1187)
IQKEIDRLNEVAKNLNESLIDLQELGK
>15756:1:P-72
VRYLEANIEELLKKAEEQQKKNEEELKKLEK
>6039:1:
PGIWQLDCTHLEGKI
>15243:1:
ADLEVVAATHVLVA
>15613:1:LP-52
WEQKIEELLKKAEEQQKKNEEELKKLEX
>6347:1:
LLEYS
>5992:1:HIV-1 RT (156-175)
SPAIFQSSMTKILEPFRKQN
>6717:1:P4762
WDRGNVTLLCDCPNGPWVWVPAFCQAVG
>15701:1:RSV Fgp (497-515)[E15A;K2R-ALA-4-pen; Q5,A8,K12 -S-ALA-4-pen]
EXINXSLXFIRXSDALLHNV
>15351:1:SARS-S (892-931)
GVTQNVLYENQKQIANQFNKAISQIQESLTTTSTALGKLQ
>15644:1:SARS-CoV Sgp (598–617)[S607P]
YQDVNCTDVPTAIHADQLTP
>15214:1:MERS-CoV-HR2P [T1263E,L1267R]
SLTQINTTLLDLEYEMRSLQQVVKALNESYIDLKEL
>9374:1:Ac-LK-NH2
LKKLLKLLKKLLKLAG
>6214:1:IN (90-97)
PAETGQET
>15594:1:Dermaseptin S4 (6-28)
LLKKVLKAAAKAALNAVLVGANA
>5984:1:Apelin-11
PRLSHKGPMPF
>6351:1:
LEYS
>15347:1:HCV (1975-1992)[E12K]
SWLRDIWDWICKVLSDFK
>15717:1:FIV Egp (739-773)
TKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKWEDW
>13339:1:D1A22
FLFAFRIFKRVFKKFRKLFKRAF
>6097:1:
TTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAILREL
>15202:1:SARS-CoV (1075–1093)
GVFVFNGTSWFITQRNFFS
>12197:1:Cycloviolin B
GTACGESCYVLPCFTVGCTCTSSQCFKN
>15652:1: 
>15652:2: 
>15486:1:MTSC28EK
MTWEEWDKKIEEYTKKIEELIKKSEEQQKK
>3942:1:Maximin-H5
ILGPVLGLVSDTLDDVLGIL
>5896:1:EBR24
AEPERRNIKYL
>3807:1:Retrocyclin-1, RC-100
GICRCICGRGICRCICGR
>1990:1:Caerin-1.6
GLFSVLGAVAKHVLPHVVPVIAEKL
>15469:1:SC28EK
WEEWDKKIEEYTKKIEELIKKSEEQQKK
>15193:1:
IEEIQKKIEEIQKKIEEIQKKIEEIQKKIEEIQKKXK
>6185:1:
LQQLLFIHFRAGRRRRRRRR
>15740:1:LP-75
EMTWEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEX
>15310:1:SARS-CoV-S (1150-1189)
DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE
>15605:1:
EMTWEEWEKKIEEYIKKIEEILKKSQNQQIDLGSGX
>18467:1:Asperterrestide A
Xaix
>15255:1:
KKKKVVLATYVLV
>360:1:Magainin-2 	 
GIGKFLHSAKKFGKAFVGEIMNS
>15412:1:CSFV gp (2688-2675)
ILELLYKFRDNIKSSVRE
>15557:1:Alloferon [H1PHE(4-OMe)]
XGVSGHGQHGVHG
>15804:1:SARS-CoV Sgp (604-625)
TDVSTAIHADQLTPAWRIYSTG
>6392:1:
RMKQIEDKIEEIESKPKKIENEIARIKKLLQLTVWGPKQLQARIL
>15384:1:WQ-IDL
WEEWDKKIEEYTKKIEELIKKSQNQQIDL
>6404:1:
RMKQIEDKIEEIESKIKKIENEIARIKKLLQLTVWGIKQLQARIL
>6054:1:HIV-1 integrase (196-206)
AGERIVDIIA
>16547:1:Deca-(ARG)7
wrrrrrrrG
>15691:1:RSV Fgp (497-515)[L7A;N4,A8,R11,E15 - S-ALA-4-pen]
EKIXQSAXFIXKSDXLLHNV
>2369:1:Melectin, MEP
GFLSILKKVLPKVMAHMK
>989:1:Ranatuerin-2P 
LMDTVKNVAKNLAGHMLDKLKCKITGC
>15445:1:GBV-A10 [L5,9,13I]
CWVRIGRYILRRIKTPFT
>823:1:Theta defensin 1, RTD-1 
GFCRCLCRRGVCRCICTR
>15853:1:LP-19
EMTWEEWEKKVEELEKKIEELLX
>15500:1:MT-WQ-ENK
MTWEEWDKKIEEYTKKIEELIKKSQNQQEKN
>5443:1:Peptide Ctry2459
FLGFLKNLF
>6516:1:C41 [N22X]
EWDREINNYTSLIHSLIEESQXQQEKNEQELLELDKWASLW
>7757:1:
HRILMRIRQMAT
>15279:1:Caerin 1.9 [V13L]
GLFGVLGSIAKHLLPHVVPVIAEKL
>15783:1:Claudin-1 (20–37)
GAIVSTALPQWRIYSYAG
>15296:1: 
>15296:2: 
>10094:1:Dermaseptin-S1 (1-12)
ALWKTMLKKLGT
>13342:1:D1D2
FAIAIKAIKKAIKKIKKAIKKAI
>835:1:Maximin 3 
GIGGKILSGLKTALKGAAKELASTYLH
>15453:1:HCV gp (696–710), E2-79
LHQNIVDVQYMYGLS
>15516:1:DENV-2 gp (700-708)
WDFGSLGGV
>6629:1:Enfuvirtide [S138L], T-20 [S138L]
YTSLIHSLIEELQNQQEKNEQELLELDKWASLWNWF
>5906:1:EBR28 [K10A]
YQLLIRMIYANI
>15795:1:Claudin-7 (1-18)
MANSGLQLLGFSMALLGW
>11386:1:Cyclic Protegrin 1 [R4C,G17C], Cyclic PG-1 [R4C,G17C]
RGGCLCYCRRRFCVCVCR
>6150:1:
LQQLLFIHFRIGRRRRRRRR
>6445:1:
WXEWDRKIEEYTKKIKKLIEESQEQQEKNEKELK
>6015:1:
AEAMSQVT
>5269:1:Elafin
AQEPVKGPVSTKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ
>15280:1:SARS-CoV-S (215-232), peptide 9626
TLKPIFKLPLGINITNFR
>15404:1:Penetratin - CP5-46-A-4D5E
RQIKIWFQNRRMKWKKGELDELVYLLDGPGYDPIHS
>4643:1:NS5A-derived peptide C5A [I10E]
SWLRDIWDWECEVLSDFK
>15541:1:Alloferon (1-7)
HGVSGHG
>6107:1:
TTWEAWDRAIAEYAARIEALIRALQELQEKLEAILREL
>6557:1:N23
RQLLSGIVQQQNNLLRAIEAQQH
>15238:1:HR2PM2, HR2P [T1263E;L1267K;S1268K;Q1270,1271E;A1275K;N1277E]
SLTQINTTLLDLEYEMKKLEEVVKKLEESYIDLKEL
>15668:1:LP-82
WEQKIEELLKKAEEQQKKNEEELKKLEX
>15392:1:C-MapoE (123-154), mhEP
CEEIRARLSTHLRKMRKRLMRDADDLQKRLAVY
>2451:1:Varv E, Varv peptide E
GLPICGETCVGGTCNTPGCSCSWPVCTRN
>15687:1:RSV Fgp (497-515)[K2A;N4,A8,R11,E15 - S-ALA-4-pen]
EAIXQSLXFIXKSDXLLHNV
>16551:1:Dodeca-(ARG)8
wrrrrrrrrG
>6035:1:
KCQLKGEAMHGQVDC
>18538:1:Alisporivir, Debio-025
XxXVXAaXXXX
>7761:1:
LMRIR
>6520:1:C41 -X
EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWX
>15166:1:229E-HCoV-HR2P
VVEQYNQTILNLTSEISTLENKSAELNYTVQKLQTLIDNINSTLVDLKWL
>15536:1:Alloferon (9-13)
HGVHG
>6259:1:IN (129-139)[E10A]
ACWWAGIKQAF
>4634:1:NS5A-derived peptide C5A [V13L]
SWLRDIWDWICELLSDFK
>19000:1:Xylapeptide A
LXXVa
>1820:1:Esculentin-2P
GFSSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC
>15473:1:SC24EK
WEEWDKKIEEYTKKIEELIKKSEE
>15189:1:
IEEISKKIEEISKKIEEISKKIEEISKKIEEISKKXK
>6062:1:
TTWEEWDREINEYTSRIESLIRESQEQQEKNEQELREL
>6432:1:
EFVFLM
>6577:1:
SGIVQQLNNQLRAEEANQHLEQLSVWGSKQNQARRLK
>15218:1:MERS-S (1260-1280) [L1,Y5Ala-4-pen]
XDLTXEMLSLQQVVKALNESY
>16967:1:SARS-CoV-2-S (1172-1205), IPB03
INASVVNIQKEIDRLNEVAKNLNESLIDLQELGK
>15648:1:SARS-CoV Sgp (1161–1180)[K1163E]
IQEEIDRLNEVAKNLNESLI
>15561:1:Eval418-FH4
LWHHIWNTVHHLI
>15424:1:GBV-A12
VRLGRYLLRRLKTPFTRL
>141:1:LL-37 (1-23)[F4,5L]
LLGDLLRKSKEKIGKEFKRIVQR
>6424:1:
FVFLM
>16137:1:Temporin-G, Temporin-1Tg
FFPVIGRILNGIL
>13335:1:D5C1
KRKRAVKRVGRRLKKLARKIARLGVAKLAGLRAVKLF
>6074:1:GLK-19r6
GLRRLLGRLLRRLGRLLLR
>16971:1:SARS-CoV-2-S (1179-1211), IPB07
IQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK
>6561:1:
RGGLSGIVQQQNNLLRAIEAQQHLLQ
>6218:1:IN (114-121)
HTDNGSNF
>5967:1:Vif (155-166)
KPKQIKPPLPSV
>6648:1:
GKKYRRFRWKFKFGKWFWFG
>157:1:Cathelicidin-6 (1-18)[F6,10Phg;L17I]
GRFKRXRKKXKKLFKKIS
>5988:1:Caps-MT
APKEWMAWAREIAAYAKLIAALIKQGI
>1162:1:Drosocin
GKPRPYXPRPXSHPRPIRV
>15598:1:Pa-MAP3, Antifreeze peptide analogue
LAAKLTKAAKLTAALTKLAAALTAAAT
>12573:1:Antimicrobial peptide 1, AamAP1[P7R; H8K]
FLFSLIRKAIGGLISAFK
>8197:1:Dermal antimicrobial peptide Hs-1
FLPLILPSIVTALSSFLKQG
>6023:1:
AEASQVTNTATIM
>6536:1:ACT- N27
RQLLSGIVQQQNNLLRAIEAQQHLLQK
>15259:1:PEDV-S HR2L, PCov-S HR2L
FNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWLNRVE
>5930:1:Vif (78-92)
DWHLGQGVSIEWRKK
>15520:1:Complement C3c (1321-1337), S17K
SEETKENEGFTVTAEGK
>15170:1:HCoV-NL63-HR2P
DLTPFNLTYLNLSSELKQLEAKTASLFQTTVELQGLIDQINSTYVDLKLL
>15465:1:SC32EK
WEEWDKKIEEYTKKIEELIKKSEEQQKKNEKE
>550:1:M-zodatoxin-Lt3a, Latarcin-3a, Ltc-3a, La47
SWKSMAKKLKEYMEKLKQRA
>15222:1:MERS-S (1260-1280) [L8,Q12Ala-4-pen]
LDLTYEMXSLQXVVKALNESY
>15672:1:LP-91
WEQKIEELLKKAEEQQKKNEEELKX
>15388:1:MERS-S (1254-1286) [Q1E, I2A]
EANTTLLDLTYEMLSLQQVVKALNESYIDLKEL
>15367:1:HCV gp (710-724)
VSFAIKWEYVLLLFL
>15737:1:LP-72
VRYLEANIEELLKKAEEQQKKNEEELKKLEX
>6058:1:
WQEWEQKITALLEQAQIQQEKNEYELQKLDKWASLWEWF
>6408:1:
KQKKIENEIARIKKLLQLTVWGIKQLQARIL
>2298:1:Maculatin 1.3
GLLGLLGSVVSHVVPAIVGHF
>6721:1:
LSDSPNGPWVWVPAFSQAVG
>6371:1:
WQCLTLTHRG
>2277:1:Uperin 7.1 [V5I,V6I,K8H,A12E,L13V]
GWFDIIKKIASEL
>15275:1:Surfactin
ELlVDlL
>4198:1:Tilapia piscidin 3, TP3
FIHHIIGGLFSVGKHIHSLIHGH
>15330:1:HCV (1975-1994)[L3R,R4L,D5I,I6D]
SWRLIDWDWICEVLSDFK
>18502:1:Euryjanicin B
ATPFVPP
>15449:1:GBV-A10 [Y8E]
CWVRLGRELLRRLKTPFT
>2365:1:Desertcolin 1
GLADFLNKAVGKVVDFVKS
>6263:1:IN (97-108)[W12L]
TAYFLLKLAGRL
>6633:1:Enfuvirtide [S138T], T-20 [S138T]
YTSLIHSLIEETQNQQEKNEQELLELDKWASLWNWF
>15263:1:SR9EK13
ISGINASVVNIQEEIKKLNEEAKKLNESLIDLQEL
>15326:1:HCV (1973-1992)
SGSWLRDIWDWICEVLSDFK
>6019:1:
VTN
>6449:1:
WEEWDKKIEEYTKKIEELIKKSEEQQKKNEEELKK
>2373:1:Styelin-A
GFGKAFHSVSNFAKKHKTA
>6625:1:RhoA scrmbl
DDMSVISELICTSPLDFIN
>15664:1:LP-77
WEQKIEELLKKAEEQQKKNEEELKKLEX
>15234:1:MERS-S (1260-1280) [Q12,A16Ala-4-pen]
LDLTYEMLSLQXVVKXLNESY
>17209:1:ACE2 (37-45)
EDLFYQSSL
>15721:1:LP-55
WEQKIEELLKKAEEQQKKNEEELKKX
>15371:1:HCV gp (710-720)
VSFAIKWEYVL
>15408:1:HPgV gp (1948-1965), GBV-A gp (1948-1965)
LLDWCVRLGRYLLRRLKT
>6222:1:IN (165-175)
VRDQAEHLKT
>6388:1:
SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
